
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Clinical significance of androgen receptor in unilateral invasive breast cancer in women - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="15251E048AEF26F3051E0400439B7F8F.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="eurjmedres">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374384/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="European Journal of Medical Research">
<meta name="citation_title" content="Clinical significance of androgen receptor in unilateral invasive breast cancer in women">
<meta name="citation_author" content="Menghan Cao">
<meta name="citation_author_institution" content="Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China">
<meta name="citation_author" content="Di Pan">
<meta name="citation_author_institution" content="Department of Oncology, Nanjing Medical University, Nanjing, China">
<meta name="citation_author" content="Yuqi Li">
<meta name="citation_author_institution" content="School of Laboratory Medicine, Bengbu Medical University, Bengbu, China">
<meta name="citation_author" content="Zicheng Pei">
<meta name="citation_author_institution" content="Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China">
<meta name="citation_author" content="Runbang Wang">
<meta name="citation_author_institution" content="The First College of Clinical Medicine, Xuzhou Medical University, Xuzhou, China">
<meta name="citation_author" content="Bo Zhang">
<meta name="citation_author_institution" content="Department of Radiation Therapy, Xuzhou Xinjiankang Hospital, Xuzhou, China">
<meta name="citation_author" content="Chaorong Bian">
<meta name="citation_author_institution" content="The First College of Clinical Medicine, Xuzhou Medical University, Xuzhou, China">
<meta name="citation_author" content="Qinghao Gu">
<meta name="citation_author_institution" content="The First College of Clinical Medicine, Xuzhou Medical University, Xuzhou, China">
<meta name="citation_author" content="Pengfei Qu">
<meta name="citation_author_institution" content="Department of Gastroenterology, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China">
<meta name="citation_author" content="Chenchen Yu">
<meta name="citation_author_institution" content="The First College of Clinical Medicine, Xuzhou Medical University, Xuzhou, China">
<meta name="citation_author" content="Haonan Liu">
<meta name="citation_author_institution" content="Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China">
<meta name="citation_author" content="Zhengxiang Han">
<meta name="citation_author_institution" content="Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China">
<meta name="citation_publication_date" content="2025 Aug 23">
<meta name="citation_volume" content="30">
<meta name="citation_firstpage" content="793">
<meta name="citation_doi" content="10.1186/s40001-025-03072-7">
<meta name="citation_pmid" content="40846987">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374384/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374384/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374384/pdf/40001_2025_Article_3072.pdf">
<meta name="description" content="To assess the prognostic relevance of androgen receptor (AR) expression in patients following modified radical surgery for invasive breast cancer. A cohort of 515 patients who underwent modified radical mastectomy for breast cancer from July 2016 to ...">
<meta name="og:title" content="Clinical significance of androgen receptor in unilateral invasive breast cancer in women">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="To assess the prognostic relevance of androgen receptor (AR) expression in patients following modified radical surgery for invasive breast cancer. A cohort of 515 patients who underwent modified radical mastectomy for breast cancer from July 2016 to ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374384/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12374384">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s40001-025-03072-7"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/40001_2025_Article_3072.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12374384%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12374384/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12374384/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374384/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-eurjmedres.png" alt="European Journal of Medical Research logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to European Journal of Medical Research" title="Link to European Journal of Medical Research" shape="default" href="https://eurjmedres.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Eur J Med Res</button></div>. 2025 Aug 23;30:793. doi: <a href="https://doi.org/10.1186/s40001-025-03072-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s40001-025-03072-7</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Eur%20J%20Med%20Res%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Eur%20J%20Med%20Res%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Eur%20J%20Med%20Res%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Eur%20J%20Med%20Res%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Clinical significance of androgen receptor in unilateral invasive breast cancer in women</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cao%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Menghan Cao</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Menghan Cao</span></h3>
<div class="p">
<sup>1</sup>Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cao%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Menghan Cao</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pan%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Di Pan</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Di Pan</span></h3>
<div class="p">
<sup>2</sup>Department of Oncology, Nanjing Medical University, Nanjing, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pan%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Di Pan</span></a>
</div>
</div>
<sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Yuqi Li</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Yuqi Li</span></h3>
<div class="p">
<sup>3</sup>School of Laboratory Medicine, Bengbu Medical University, Bengbu, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yuqi Li</span></a>
</div>
</div>
<sup>3,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pei%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Zicheng Pei</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Zicheng Pei</span></h3>
<div class="p">
<sup>1</sup>Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pei%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zicheng Pei</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Runbang Wang</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Runbang Wang</span></h3>
<div class="p">
<sup>4</sup>The First College of Clinical Medicine, Xuzhou Medical University, Xuzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Runbang Wang</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Bo Zhang</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Bo Zhang</span></h3>
<div class="p">
<sup>5</sup>Department of Radiation Therapy, Xuzhou Xinjiankang Hospital, Xuzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Bo Zhang</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bian%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Chaorong Bian</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Chaorong Bian</span></h3>
<div class="p">
<sup>4</sup>The First College of Clinical Medicine, Xuzhou Medical University, Xuzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bian%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Chaorong Bian</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gu%20Q%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Qinghao Gu</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Qinghao Gu</span></h3>
<div class="p">
<sup>4</sup>The First College of Clinical Medicine, Xuzhou Medical University, Xuzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gu%20Q%22%5BAuthor%5D" class="usa-link"><span class="name western">Qinghao Gu</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Qu%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Pengfei Qu</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Pengfei Qu</span></h3>
<div class="p">
<sup>6</sup>Department of Gastroenterology, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Qu%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Pengfei Qu</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Chenchen Yu</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Chenchen Yu</span></h3>
<div class="p">
<sup>4</sup>The First College of Clinical Medicine, Xuzhou Medical University, Xuzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Chenchen Yu</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Haonan Liu</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Haonan Liu</span></h3>
<div class="p">
<sup>1</sup>Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Haonan Liu</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Han%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Zhengxiang Han</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Zhengxiang Han</span></h3>
<div class="p">
<sup>1</sup>Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Han%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zhengxiang Han</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China </div>
<div id="Aff2">
<sup>2</sup>Department of Oncology, Nanjing Medical University, Nanjing, China </div>
<div id="Aff3">
<sup>3</sup>School of Laboratory Medicine, Bengbu Medical University, Bengbu, China </div>
<div id="Aff4">
<sup>4</sup>The First College of Clinical Medicine, Xuzhou Medical University, Xuzhou, China </div>
<div id="Aff5">
<sup>5</sup>Department of Radiation Therapy, Xuzhou Xinjiankang Hospital, Xuzhou, China </div>
<div id="Aff6">
<sup>6</sup>Department of Gastroenterology, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Apr 4; Accepted 2025 Aug 13; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12374384  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40846987/" class="usa-link">40846987</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Objective</h3>
<p id="Par1">To assess the prognostic relevance of androgen receptor (AR) expression in patients following modified radical surgery for invasive breast cancer.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p id="Par2">A cohort of 515 patients who underwent modified radical mastectomy for breast cancer from July 2016 to November 2017 was analyzed. Immunohistochemistry was employed to determine the expression levels of AR, estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER-2), cell proliferation nuclear antigen (Ki-67), oncogene (P-53), cytokeratin 5/6 (CK5/6), topoisomerase-2 (TOPO-2), and epidermal growth factor receptor (EGFR). The correlation between AR expression and clinicopathological features as well as prognosis was examined. Multifactorial analysis using Cox proportional risk regression identified independent prognostic factors for disease-free survival (DFS), and a nomogram model was developed based on these factors.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p id="Par3">Patients in the AR-positive group demonstrated a significantly higher frequency of low histologic grade (grade 1–2), ER positive, PR positive, TOPO-2-negative, CK5/6-negative, and EGFR-negative as compared to the AR-negative group (<em>P</em> &lt; 0.05). Among ER( +)/HER-2(−) and ER( +)/HER-2( +) patients with breast cancer, AR-positive individuals exhibited prolonged DFS (<em>P</em> &lt; 0.05). Conversely, in ER(−)/HER-2( +) and ER(−)/HER-2(−) patients with breast cancer, AR expression did not significantly influence disease-free survival (<em>P</em> &gt; 0.05). Multifactorial regression analysis identified AR/ER ratio, histological classification, and lymph node metastasis as independent prognostic factors for DFS (all <em>P</em> &lt; 0.05). The developed nomogram model underscored the significance of histological classification as the primary predictive factor for patient outcomes, followed by AR/ER ratio and lymph node metastasis</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusion</h3>
<p id="Par4">AR expression holds varying prognostic implications across different breast cancer subtypes, with AR positivity indicating a favorable prognosis, particularly in ER-positive tumors.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Androgen receptors, Breast cancer, AR/ER, Endocrine resistance, Prognosis</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par5">Breast cancer stands as the most prevalent malignancy and the fifth leading cause of cancer-related mortality worldwide [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. Within China, the incidence of breast cancer has been on the rise annually, with approximately 300,000 women diagnosed each year [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Despite advancements in early diagnostic technologies, 5% to 10% of patients still present with distant metastasis at diagnosis [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. Current standard chemotherapy and hormonal treatments yield limited reduction in recurrence and metastasis, contributing to the demise of 90% of patients with breast cancer [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>–<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. Therefore, amidst the escalating incidence and mortality rates, it is imperative to identify more reliable breast cancer-related prognostic markers and novel treatment modalities.</p>
<p id="Par6">The primary risk factors for breast cancer encompass lifestyle, diet, hormones, age, gender, race, and genetic predispositions. Among them, steroid hormone receptors and their coactivators significantly influence breast cancer pathogenesis [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>, <a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. Therefore, breast cancer is widely acknowledged as a hormone-dependent tumor [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. The estrogen receptor (ER) holds relevance in breast cancer, with estrogen significantly promoting tumor growth through ER binding [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. Approximately 70% of patients with breast cancer express ER and may benefit from antiestrogen therapy [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. Androgen receptor (AR), another steroid hormone receptor and a member of the nuclear receptor family alongside ER and progesterone receptor (PR), also plays a pivotal role in breast cancer carcinogenesis. AR exhibits broader expression than ER and PR [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>], and similar to other steroid hormone receptors, it resides in the cytoplasm in the absence of androgens, forming complexes with heat shock proteins and molecular chaperones like immunophilin [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. After activation by androgens, AR dissociates from heat shock proteins, dimerizes, and translocates to the nucleus, where it binds to androgen response elements near target genes, modulating DNA transcription [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. AR dimers can both positively and negatively regulate gene transcription, influencing tumor cell differentiation, proliferation, apoptosis, and angiogenesis [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>].</p>
<p id="Par7">AR has emerged as a promising prognostic biomarker and therapeutic target in breast cancer treatment [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. Despite efforts to explore AR’s prognostic role, results remain controversial. The recent research highlights crosstalk between the AR pathway and ER, HER-2, as well as PI3K/AKT/mTOR, RAS/RAF/MAPK/ERK, and WNT/β-Catenin signaling pathways, with AR exerting differential effects across breast cancer subtypes [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. When considering the high heterogeneity of breast cancer at the clinical and molecular levels, researchers hypothesize that the prognostic effect of AR on breast cancer is closely related to breast cancer classification, although subgroup analyses have yielded inconclusive results [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>–<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. Further investigation is warranted to ascertain AR’s role across breast cancer subtypes and solidify its status as a valuable prognostic biomarker.</p>
<p id="Par8">Recently, comprehensive treatment incorporating surgery, chemotherapy, radiotherapy, molecular targeted therapy, and endocrine therapy has become standard, substantially improving patient survival rates [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. Among them, endocrine therapy constitutes a cornerstone of breast cancer treatment, significantly enhancing patient survival outcomes [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. In ER-positive breast cancer, adjuvant therapy with competitive antagonists like tamoxifen or aromatase inhibitors, which impede androgen conversion to estrogen, often proves efficacious in inhibiting disease progression [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. However, approximately half of patients with ER-positive breast cancer eventually develop endocrine resistance, posing a major clinical challenge [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]. DeAmicis et al. [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>] first reported that in human breast cancer cell line MCF-7 and animal models, high AR expression was correlated to tamoxifen treatment resistance, whereas the AR inhibitor bicalutamide sensitized tumors to tamoxifen. A study involving 192 patients with ER-positive primary breast cancer receiving adjuvant endocrine therapy with tamoxifen concluded that when the AR/ER ratio exceeds 2, tamoxifen resistance significantly increases, leading to poor prognosis [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>], suggesting that this ratio is related to the prognosis of ER-positive breast cancer.</p>
<p id="Par9">Currently, the prognostic impact of AR on breast cancer subgroups is still unclear, with limited studies investigating the AR/ER ratio as a prognostic indicator for ER-positive breast cancer. Further validation of its predictive role is warranted. This study retrospectively investigates 515 female patients with unilateral invasive breast cancer post-modified radical surgery. Stratified by ER and HER-2, patients were categorized into ER(−)/HER-2(−), ER(−)/HER-2(+), ER(+)/HER-2(−), and ER(+)/HER-2(+) groups to explore the AR expression and its prognostic significance across breast cancer subtypes. In addition, we speculate on AR’s potential as an effective target for breast cancer treatment, advocating personalized molecular-level interventions alongside standard therapies to innovate breast cancer treatment strategies.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Study design and patients</h3>
<p id="Par10">A retrospective cohort study was conducted, including 515 female patients who underwent modified radical mastectomy and received postoperative pathological confirmation of invasive breast cancer from July 1, 2017, to November 30, 2018. The Medical Ethics Committee of the Affiliated Hospital of Xuzhou Medical University approved this study. The deadline for follow-up is November 30, 2023.</p>
<p id="Par11">Inclusion criteria: (1) Female patients with an initial diagnosis of unilateral breast cancer; (2) Pathologically confirmed invasive breast cancer post-modified radical resection; (3) Availability of relatively complete clinical and pathological data; (4) Absence of distant metastasis based on the imaging evaluation; (5) Absence of significant systemic diseases affecting the heart, liver, kidney or other organs. Exclusion criteria: (1) Male breast cancer; (2) Bilateral breast cancer; (3) Occult breast cancer; (4) Prior neoadjuvant treatment; (5) Presence of significant systemic diseases affecting the heart, liver, kidney, or other organs; (6) Coexistence of other malignant tumors at initial diagnosis; (7) Palliative surgery or breast-conserving surgery; (8) Loss to follow-up.</p></section><section id="Sec4"><h3 class="pmc_sec_title">Staining method</h3>
<p id="Par12">All invasive breast cancer specimens underwent immunohistochemical staining, adhering to the kit instructions. Staining results were independently interpreted by two pathologists. The immunohistochemistry process was as follows: (1) Dewaxing: Paraffin sections were sequentially immersed in dewaxing solution I (15 min), dewaxing solution II (15 min), and dewaxing solution III (15 min), followed by immersion in absolute ethanol I and II for 5 min each, 85% alcohol for 5 min, and 75% alcohol for 5 min, then rinsed with distilled water. (2) Antigen retrieval: Tissue sections were placed in a repair box containing EDTA antigen retrieval buffer (pH 9.0) and subjected to microwave heating: 8 min at medium heat, 8 min without heat, then 7 min at medium–low heat. During this period, care was taken to avoid excessive evaporation of the buffer and drying of the slices. Following natural cooling, the slides were rinsed thrice with PBS (pH 7.4) on a shaking platform for 5 min each time. (3) Endogenous peroxidase blocking: The section was incubated with 3% hydrogen peroxide solution for 25 min at room temperature in the dark, followed by thrice washing for 5-min each time with PBS (pH 7.4) on a decolorizing shaking platform. (4) Serum blocking: Tissue was covered with 3% BSA and blocked at room temperature for 30 min. (5) Primary antibody incubation: After gently shaking off the blocking solution, the primary antibody prepared in PBS was added to the sections, followed by overnight incubation at 4℃ in a humidified chamber. Moreover, an appropriate amount of water was added to the wet box to prevent the antibody from evaporating. (6) Secondary antibody incubation: Sections were washed thrice with PBS (pH 7.4) on a shaking platform for 5 min each, then incubated with an HRP-labeled secondary antibody at room temperature for 50 min. (7) DAB color development: After washing thrice with PBS (pH 7.4) for 5 min each time, sections were incubated with freshly prepared DAB chromogenic solution, which was added dropwise into the circle. A microscope was used to control the color development time. Positive results appeared brown under microscopy. Color development was stopped by rinsing with water. (8) Nuclei counterstaining: Sections were counterstained with hematoxylin for 3 min, washed with water, differentiated with hematoxylin differentiation solution for a few seconds, rinsed again with water, returned to blue with hematoxylin blue-returning solution, and finally washed with running water. (9) Dehydration and mounting: Place the slices in 75% alcohol (5 min) – 85% alcohol (5 min) – absolute ethanol I (5 min)—absolute ethanol II (5 min)—n-butanol (5 min) – Dehydrate and become transparent in xylene I (5 min). Take the sections out of xylene to dry slightly and seal them with mounting glue. (10) Microscopic examination, image collection, and analysis.</p></section><section id="Sec5"><h3 class="pmc_sec_title">Result judgment criteria</h3>
<p id="Par13">AR, P53, TOPO-II status judgment criteria: The entire section was evaluated. The presence of dark brown particles in tumor cell nuclear staining denotes positive cells. When positive cells comprise ≥ 10%, AR, P53, and TOPO-II were categorized as positive (+). PR and ER status determination criteria: The entire section was evaluated. Brown-yellow particles in tumor cell nuclei denoted positive cells. Positive PR and ER status was affirmed when positive cells were ≥ 1%. CK5/6 status determination criteria: The entire section was evaluated. Yellow or brown granular staining in tumor cytoplasm indicated positive cells. When the number of positive cells was ≥ 10%, CK5/6 was determined to be positive (+). EGFR status determination criteria: The entire section was evaluated. Clear brown-yellow particles on the tumor cell membrane denoted positive cells. When the number of positive cells was ≥ 10%, EGFR positivity (+) was confirmed. HER-2 status judgment criteria: (1) 0: No staining or ≤ 10% of infiltrating cancer cells exhibit light and incomplete cell membrane staining; (2) 1 + : &gt; 10% of infiltrating cancer cells show light and incomplete staining; (3) 2 + : &gt; 10% of infiltrating cancer cells display weak-moderate intensity of complete cell membrane staining, or ≤ 10% of infiltrating cancer cells exhibit strong and complete cell membrane staining; (4) 3 + : &gt; 10% of infiltrating cancer cells demonstrate strong, complete, and uniform cell membrane staining. A result of 3 + in immunohistochemistry or 2 + with amplification in in situ hybridization FISH testing was deemed positive (+), while the absence of amplification rendered it negative (−). When immunohistochemistry yields 1 + or 0, it is categorized as negative (−). Ki-67 status determination standard: The percentage of positively stained nuclei in cancer cells was reported. For tumor cells with a relatively even positive cell distribution, the average Ki-67 index was calculated from three or more randomly selected invasive cancer high-power fields. If uneven positive distribution was observed, evaluation was conducted in the positive cell hotspot area across three or more high-power fields of invasive cancer. In this study, when ≥ 14% of tumor cell nuclei stained brown, Ki-67 expression was judged high (+).</p></section><section id="Sec6"><h3 class="pmc_sec_title">Assessment</h3>
<p id="Par14">The primary outcome measure is disease-free survival (DFS), defined as the duration from the first day after surgery to tumor recurrence or metastasis.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par15">Statistical analyses were performed using R 4.2.0 software. Categorical data were presented as counts and percentages. Median DFS was estimated utilizing the Kaplan–Meier method. Univariate and multivariate Cox regression analyses were conducted, with variables exhibiting <em>P</em> &lt; 0.05 in the univariate analysis included in the multivariate analysis to identify independent prognostic factors for DFS. A nomogram prediction model was constructed using independent prognostic factors derived from multivariate analysis of DFS, validated at 1, 3, and 5 years, and compared against actual outcomes. All significance tests were two-sided, with <em>P</em> &lt; 0.05 considered to indicate statistical significance.</p></section></section><section id="Sec8"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec9"><h3 class="pmc_sec_title">The relationship between AR expression and clinicopathological features</h3>
<p id="Par16">Among 515 female patients with unilateral invasive breast cancer who underwent modified radical resection, complete data were available for most pathological parameters, except for TOPO-II data in 13 patients, P-53 data in 3 patients, CK5/6 data in 3 patients. AR positivity, defined as ≥ 10% of tumor cell nuclei staining dark brown, was observed in 83.3% (429/515) of cases. Notably, AR positivity rates were significantly higher in ER-positive tumors 333 (77.62%) as compared to ER-negative tumors 96 (22.38%), and in PR-positive tumors 316 (73.66%) as compared to PR-negative tumors 113 (26.34%) (P &lt; 0.001). Furthermore, the AR-positive rate of CK5/6-positive tumors was 67 (15.73%) which was significantly lower than the AR-positive rate of CK5/6-negative breast cancer tumors 359 (84.27%) (<em>P</em> &lt; 0.001). The AR-positive rate of EGFR-positive patients was 91 (21.36%) whereas those with EGFR-negative breast cancer exhibited 335 (78.64%) (<em>P</em> &lt; 0.001). The AR-positive rate of TOPO-II positive patients was 290 (69.71%), which was significantly higher than the AR-positive rate of TOPO-II negative patients with breast cancer 126 (30.29%) (<em>P</em> = 0.004). Patients in the AR-positive group were different from those in the AR-negative group in terms of age, tumor size, menstrual status, Histological grading, lymph node metastasis, tumor thrombus presence, nerve or vessel invasion, HER-2, Ki-67, and P-53 expressions was no significant difference between the patient groups (<em>P</em> &gt; 0.05).In terms of histological subtypes, five cases of apocrine carcinoma were identified, all within the AR-positive group (1.17%). Invasive ductal carcinoma was more prevalent in the AR-positive group (93.01%) than in the AR-negative group (88.37%), whereas no clear trend in distribution was observed for invasive lobular carcinoma, mucinous carcinoma, tubular carcinoma, metaplastic carcinoma, or other special subtypes between the two groups (<em>P</em> = 0.119) (Table <a href="#Tab1" class="usa-link">1</a>).
</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Relationship between AR expression and clinicopathological characteristics of invasive breast cancer</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Variables</th>
<th align="left" colspan="1" rowspan="1">AR-negative<br>(n = 86)</th>
<th align="left" colspan="1" rowspan="1">AR-positive<br>(n = 429)</th>
<th align="left" colspan="1" rowspan="1">Statistic</th>
<th align="left" colspan="1" rowspan="1">P</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="3" rowspan="1">TOPO—2</td>
<td align="center" colspan="1" rowspan="1">
<em>χ</em><sup><em>2</em></sup> = 8.19</td>
<td align="center" colspan="1" rowspan="1">0.004</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Negative</td>
<td align="center" colspan="1" rowspan="1">13 (15.12)</td>
<td align="center" colspan="1" rowspan="1">126 (30.29)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Positive</td>
<td align="center" colspan="1" rowspan="1">73 (84.88)</td>
<td align="center" colspan="1" rowspan="1">290 (69.71)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Age (years)</td>
<td align="center" colspan="1" rowspan="1">
<em>χ</em><sup><em>2</em></sup> = 2.11</td>
<td align="center" colspan="1" rowspan="1">0.348</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  ≤ 35</td>
<td align="center" colspan="1" rowspan="1">8 (9.30)</td>
<td align="center" colspan="1" rowspan="1">28 (6.53)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 35–60</td>
<td align="center" colspan="1" rowspan="1">50 (58.14)</td>
<td align="center" colspan="1" rowspan="1">283 (65.97)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  &gt; 60</td>
<td align="center" colspan="1" rowspan="1">28 (32.56)</td>
<td align="center" colspan="1" rowspan="1">118 (27.51)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">BMI</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 1.88</td>
<td align="center" colspan="1" rowspan="1">0.392</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  &lt; 25</td>
<td align="center" colspan="1" rowspan="1">25 (29.07)</td>
<td align="center" colspan="1" rowspan="1">118 (27.51)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  ≥ 30</td>
<td align="center" colspan="1" rowspan="1">28 (32.56)</td>
<td align="center" colspan="1" rowspan="1">172 (40.09)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 25–29</td>
<td align="center" colspan="1" rowspan="1">33 (38.37)</td>
<td align="center" colspan="1" rowspan="1">139 (32.40)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Smoking</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 0.29</td>
<td align="center" colspan="1" rowspan="1">0.865</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Current</td>
<td align="center" colspan="1" rowspan="1">22 (25.58)</td>
<td align="center" colspan="1" rowspan="1">122 (28.44)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Never</td>
<td align="center" colspan="1" rowspan="1">16 (18.60)</td>
<td align="center" colspan="1" rowspan="1">77 (17.95)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Past</td>
<td align="center" colspan="1" rowspan="1">48 (55.81)</td>
<td align="center" colspan="1" rowspan="1">230 (53.61)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Benign breast disease</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 0.21</td>
<td align="center" colspan="1" rowspan="1">0.647</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="center" colspan="1" rowspan="1">58 (67.44)</td>
<td align="center" colspan="1" rowspan="1">300 (69.93)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="center" colspan="1" rowspan="1">28 (32.56)</td>
<td align="center" colspan="1" rowspan="1">129 (30.07)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Menstrual status</td>
<td align="center" colspan="1" rowspan="1">
<em>χ</em><sup><em>2</em></sup> = 0.07</td>
<td align="center" colspan="1" rowspan="1">0.798</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Premenopausal</td>
<td align="center" colspan="1" rowspan="1">41 (47.67)</td>
<td align="center" colspan="1" rowspan="1">211 (49.18)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Menopausal</td>
<td align="center" colspan="1" rowspan="1">45 (52.33)</td>
<td align="center" colspan="1" rowspan="1">218 (50.82)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Tumor size (cm)</td>
<td align="center" colspan="1" rowspan="1">
<em>χ</em><sup><em>2</em></sup> = 0.55</td>
<td align="center" colspan="1" rowspan="1">0.459</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  ≤ 2</td>
<td align="center" colspan="1" rowspan="1">31 (36.05)</td>
<td align="center" colspan="1" rowspan="1">173 (40.33)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  &gt; 2</td>
<td align="center" colspan="1" rowspan="1">55 (63.95)</td>
<td align="center" colspan="1" rowspan="1">256 (59.67)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Lymph node metastasis</td>
<td align="center" colspan="1" rowspan="1">
<em>χ</em><sup><em>2</em></sup> = 6.81</td>
<td align="center" colspan="1" rowspan="1">0.078</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> N0</td>
<td align="center" colspan="1" rowspan="1">41 (47.67)</td>
<td align="center" colspan="1" rowspan="1">265 (61.77)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> N1</td>
<td align="center" colspan="1" rowspan="1">27 (31.40)</td>
<td align="center" colspan="1" rowspan="1">97 (22.61)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> N2</td>
<td align="center" colspan="1" rowspan="1">11 (12.79)</td>
<td align="center" colspan="1" rowspan="1">48 (11.19)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> N3</td>
<td align="center" colspan="1" rowspan="1">7 (8.14)</td>
<td align="center" colspan="1" rowspan="1">19 (4.43)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Histological grading</td>
<td align="center" colspan="1" rowspan="1">
<em>χ</em><sup><em>2</em></sup> = 0.83</td>
<td align="center" colspan="1" rowspan="1">0.362</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 1–2</td>
<td align="center" colspan="1" rowspan="1">65 (75.58)</td>
<td align="center" colspan="1" rowspan="1">343 (79.95)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 3</td>
<td align="center" colspan="1" rowspan="1">21 (24.42)</td>
<td align="center" colspan="1" rowspan="1">86 (20.05)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">ER</td>
<td align="center" colspan="1" rowspan="1">
<em>χ</em><sup><em>2</em></sup> = 83.26</td>
<td align="center" colspan="1" rowspan="1"> &lt;.001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Negative</td>
<td align="center" colspan="1" rowspan="1">62 (72.09)</td>
<td align="center" colspan="1" rowspan="1">96 (22.38)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Positive</td>
<td align="center" colspan="1" rowspan="1">24 (27.91)</td>
<td align="center" colspan="1" rowspan="1">333 (77.62)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">PR</td>
<td align="center" colspan="1" rowspan="1">
<em>χ</em><sup><em>2</em></sup> = 98.60</td>
<td align="center" colspan="1" rowspan="1"> &lt; 0.001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Negative</td>
<td align="center" colspan="1" rowspan="1">71 (82.56)</td>
<td align="center" colspan="1" rowspan="1">113 (26.34)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Positive</td>
<td align="center" colspan="1" rowspan="1">15 (17.44)</td>
<td align="center" colspan="1" rowspan="1">316 (73.66)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">KI67</td>
<td align="center" colspan="1" rowspan="1">
<em>χ</em><sup><em>2</em></sup> = 3.19</td>
<td align="center" colspan="1" rowspan="1">0.074</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  &lt; 14%</td>
<td align="center" colspan="1" rowspan="1">4 (4.65)</td>
<td align="center" colspan="1" rowspan="1">47 (10.96)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  ≥ 14%</td>
<td align="center" colspan="1" rowspan="1">82 (95.35)</td>
<td align="center" colspan="1" rowspan="1">382 (89.04)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">HER2</td>
<td align="center" colspan="1" rowspan="1">
<em>χ</em><sup><em>2</em></sup> = 0.66</td>
<td align="center" colspan="1" rowspan="1">0.418</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Negative</td>
<td align="center" colspan="1" rowspan="1">61 (70.93)</td>
<td align="center" colspan="1" rowspan="1">285 (66.43)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Positive</td>
<td align="center" colspan="1" rowspan="1">25 (29.07)</td>
<td align="center" colspan="1" rowspan="1">144 (33.57)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">P53</td>
<td align="center" colspan="1" rowspan="1">
<em>χ</em><sup><em>2</em></sup> = 1.06</td>
<td align="center" colspan="1" rowspan="1">0.304</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Negative</td>
<td align="center" colspan="1" rowspan="1">39 (45.88)</td>
<td align="center" colspan="1" rowspan="1">222 (51.99)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Positive</td>
<td align="center" colspan="1" rowspan="1">46 (54.12)</td>
<td align="center" colspan="1" rowspan="1">205 (48.01)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">CK56</td>
<td align="center" colspan="1" rowspan="1">
<em>χ</em><sup><em>2</em></sup> = 41.02</td>
<td align="center" colspan="1" rowspan="1"> &lt; 0.001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Negative</td>
<td align="center" colspan="1" rowspan="1">46 (53.49)</td>
<td align="center" colspan="1" rowspan="1">359 (84.27)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Positive</td>
<td align="center" colspan="1" rowspan="1">40 (46.51)</td>
<td align="center" colspan="1" rowspan="1">67 (15.73)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">EGFR</td>
<td align="center" colspan="1" rowspan="1">
<em>χ</em><sup><em>2</em></sup> = 62.00</td>
<td align="center" colspan="1" rowspan="1"> &lt;0.001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Negative</td>
<td align="center" colspan="1" rowspan="1">31 (36.47)</td>
<td align="center" colspan="1" rowspan="1">335 (78.64)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Positive</td>
<td align="center" colspan="1" rowspan="1">54 (63.53)</td>
<td align="center" colspan="1" rowspan="1">91 (21.36)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Vascular invasion</td>
<td align="center" colspan="1" rowspan="1">
<em>χ</em><sup><em>2</em></sup> = 2.63</td>
<td align="center" colspan="1" rowspan="1">0.105</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="center" colspan="1" rowspan="1">70 (81.40)</td>
<td align="center" colspan="1" rowspan="1">377 (87.88)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="center" colspan="1" rowspan="1">16 (18.60)</td>
<td align="center" colspan="1" rowspan="1">52 (12.12)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Nerve invasion</td>
<td align="center" colspan="1" rowspan="1">
<em>χ</em><sup><em>2</em></sup> = 1.24</td>
<td align="center" colspan="1" rowspan="1">0.266</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="center" colspan="1" rowspan="1">79 (91.86)</td>
<td align="center" colspan="1" rowspan="1">376 (87.65)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="center" colspan="1" rowspan="1">7 (8.14)</td>
<td align="center" colspan="1" rowspan="1">53 (12.35)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Cancer thrombus</td>
<td align="center" colspan="1" rowspan="1">
<em>χ</em><sup><em>2</em></sup> = 0.90</td>
<td align="center" colspan="1" rowspan="1">0.343</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="center" colspan="1" rowspan="1">80 (93.02)</td>
<td align="center" colspan="1" rowspan="1">412 (96.04)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="center" colspan="1" rowspan="1">6 (6.98)</td>
<td align="center" colspan="1" rowspan="1">17 (3.96)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Histological type</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">0.119</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Apocrine carcinoma</td>
<td align="center" colspan="1" rowspan="1">0 (0.00)</td>
<td align="center" colspan="1" rowspan="1">5 (1.17)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Metaplastic carcinoma</td>
<td align="center" colspan="1" rowspan="1">1 (1.16)</td>
<td align="center" colspan="1" rowspan="1">1 (0.23)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Invasive ductal carcinoma</td>
<td align="center" colspan="1" rowspan="1">76 (88.37)</td>
<td align="center" colspan="1" rowspan="1">399 (93.01)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Invasive lobular carcinoma</td>
<td align="center" colspan="1" rowspan="1">2 (2.33)</td>
<td align="center" colspan="1" rowspan="1">8 (1.86)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Mucinous carcinoma</td>
<td align="center" colspan="1" rowspan="1">2 (2.33)</td>
<td align="center" colspan="1" rowspan="1">8 (1.86)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Tubular carcinoma</td>
<td align="center" colspan="1" rowspan="1">1 (1.16)</td>
<td align="center" colspan="1" rowspan="1">4 (0.93)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Other types</td>
<td align="center" colspan="1" rowspan="1">4 (4.65)</td>
<td align="center" colspan="1" rowspan="1">4 (0.93)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Any adjuvant Therapy</td>
<td align="center" colspan="1" rowspan="1">
<em>χ</em><sup>2</sup> = 1.20</td>
<td align="center" colspan="1" rowspan="1">0.272</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="center" colspan="1" rowspan="1">13 (15.12)</td>
<td align="center" colspan="1" rowspan="1">47 (10.96)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="center" colspan="1" rowspan="1">73 (84.88)</td>
<td align="center" colspan="1" rowspan="1">382 (89.04)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p18"><p>Data in brackets represent the percentages of patients. TOPO-2: Topoisomerase-2; AR: Androgen receptor; EGFR: Epidermal growth factor receptor; ER: Estrogen receptor; HER-2: Human epidermal growth factor receptor-2; HR: Hormone receptor; PR: Progesterone receptor</p></div></div></section></section><section id="Sec10"><h3 class="pmc_sec_title">Prognostic analysis of AR and all female unilateral invasive breast cancer</h3>
<p id="Par17">A total of 515 cases of female unilateral invasive breast cancer were analyzed for DFS. DFS curve analysis showed that there was no statistically significant difference in prognosis between the two groups (<em>P</em> = 0.093) (Fig. <a href="#Fig1" class="usa-link">1</a>).</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374384_40001_2025_3072_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7a/12374384/be8e9b346244/40001_2025_3072_Fig1_HTML.jpg" loading="lazy" id="MO1" height="536" width="783" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Disease-free survival curves for breast cancer patients</p></figcaption></figure></section><section id="Sec11"><h3 class="pmc_sec_title">Analysis of expression and prognosis of AR and four subgroups of invasive breast cancer</h3>
<p id="Par18">The 515 female patients with unilateral invasive breast cancer patients were divided into four subgroups based on ER and HER-2 expression: ER(−)/HER-2(−), ER−)/HER-2(+), ER(+)/HER-2(−), and ER(+)/HER-2(+). Among them, the positive expression rate of AR in the ER(−)/HER-2(−) group was 28 (6.53%), 68 (15.85%) in the ER(+)/HER-2(−) group, 257 (59.91%) in the ER(+)/HER-2(+) group, and 76 (17.72%) in the ER(-)/HER-2(+) group, with the difference being statistically significant (<em>χ</em><em>2</em> = 128.970, <em>P</em> &lt; 0.001) (Fig. <a href="#Fig2" class="usa-link">2</a>) (Table <a href="#Tab2" class="usa-link">2</a>).</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7a/12374384/a8d2be7e60bb/40001_2025_3072_Fig2_HTML.jpg" loading="lazy" id="MO2" height="410" width="629" alt="Fig. 2"></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>AR expression in invasive breast cancer in different subgroups</p></figcaption></figure><section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Differences in the expression of AR in different subgroups</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Variables</th>
<th align="left" colspan="1" rowspan="1">AR-negative<br>(n = 86)</th>
<th align="left" colspan="1" rowspan="1">AR-positive<br>(n = 429)</th>
<th align="left" colspan="1" rowspan="1">Statistic</th>
<th align="left" colspan="1" rowspan="1">P</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Typing</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">
<em>χ</em><sup><em>2</em></sup> = 128.97</td>
<td align="left" colspan="1" rowspan="1"> &lt;.001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ER-HER-</td>
<td align="left" colspan="1" rowspan="1">44 (51.16)</td>
<td align="left" colspan="1" rowspan="1">28 (6.53)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ER-HER + </td>
<td align="left" colspan="1" rowspan="1">18 (20.93)</td>
<td align="left" colspan="1" rowspan="1">68 (15.85)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ER + HER + </td>
<td align="left" colspan="1" rowspan="1">7 (8.14)</td>
<td align="left" colspan="1" rowspan="1">76 (17.72)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ER + HER2-</td>
<td align="left" colspan="1" rowspan="1">17 (19.77)</td>
<td align="left" colspan="1" rowspan="1">257 (59.91)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p24"><p>Data in brackets represent the percentages of patients. <em>ER</em>: Estrogen receptor; <em>HER-2</em>: Human epidermal growth factor receptor-2</p></div></div></section></section><section id="Sec12"><h3 class="pmc_sec_title">Analysis of AR expression and prognosis of ER(+)/HER-2(−) invasive breast cancer</h3>
<p id="Par19">In the ER(+)/HER-2(−) invasive breast cancer cohort, the 5-year DFS rate of patients in the AR-positive group was 86.8%, while that in the AR-negative group was 64.7%. Comparative analysis of the DFS curves revealed a significantly better prognosis in the AR-positive group as compared to the AR-negative group (Log Rank test <em>P</em> = 0.009) (Fig. <a href="#Fig3" class="usa-link">3</a>).</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374384_40001_2025_3072_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7a/12374384/ee851084a283/40001_2025_3072_Fig3_HTML.jpg" loading="lazy" id="MO3" height="543" width="778" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Kaplan–Meier curve analysis of the AR expression and disease-free survival in ER(+)/HER-2(−) invasive breast cancer</p></figcaption></figure></section><section id="Sec13"><h3 class="pmc_sec_title">Analysis of AR expression and prognosis of ER(+)/HER-2(+) invasive breast cancer</h3>
<p id="Par20">In ER(+)/HER-2(+) invasive breast cancer, the 5-year DFS rate of patients in the AR-positive group was 91.5%, which was significantly higher than the patients in the AR-negative group (57.1%). DFS curve analysis demonstrated a significantly better prognosis in the AR-positive group as compared to the AR-negative group, with a statistical difference in the survival curves (<em>P</em> = 0.027) (Fig. <a href="#Fig4" class="usa-link">4</a>).</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374384_40001_2025_3072_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7a/12374384/6792970ce927/40001_2025_3072_Fig4_HTML.jpg" loading="lazy" id="MO4" height="529" width="778" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Kaplan–Meier curve analysis of the relationship between the AR expression and disease-free survival in ER(+)/HER-2(+) breast cancer</p></figcaption></figure></section><section id="Sec14"><h3 class="pmc_sec_title">Analysis of AR expression and prognosis of ER(−)/HER-2(+) invasive breast cancer</h3>
<p id="Par21">In ER(−)/HER-2(+) invasive breast cancer, the 5-year DFS rate was 76.5% in the AR-positive group and 72.2% in the AR-negative. However, there was no statistical difference in the DFS curve between the two groups (Log Rank test <em>P</em> = 0.839) (Fig. <a href="#Fig5" class="usa-link">5</a><strong>)</strong>.</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374384_40001_2025_3072_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7a/12374384/3470a1e2c2bb/40001_2025_3072_Fig5_HTML.jpg" loading="lazy" id="MO5" height="503" width="778" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Kaplan–Meier curve analysis of the relationship between the AR expression and disease-free survival in ER(-)/HER-2(+) breast cancer</p></figcaption></figure></section><section id="Sec15"><h3 class="pmc_sec_title">Analysis of AR expression and prognosis of ER(−)/HER-2(−) invasive breast cancer</h3>
<p id="Par22">For ER(-)/HER-2(-) invasive breast cancer, the 5-year DFS rate was 64.3% in the AR-positive group and 75.0% in the AR-negative group. No statistically significant difference was observed in the DFS curves between the two groups (Log Rank test <em>P</em> = 0.398) (Fig. <a href="#Fig6" class="usa-link">6</a>).</p>
<figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374384_40001_2025_3072_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7a/12374384/53e8cb25a076/40001_2025_3072_Fig6_HTML.jpg" loading="lazy" id="MO6" height="536" width="779" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Kaplan–Meier curve analysis of the relationship between the AR expression and disease-free survival in ER(−)/HER-2(-) breast cancer</p></figcaption></figure></section><section id="Sec16"><h3 class="pmc_sec_title">Prognostic analysis of AR expression stratified by receipt of adjuvant therapy</h3>
<p id="Par23">To address the concern that survival analyses without adjuvant-therapy details may be incomplete, we performed Kaplan–Meier analyses within two subgroups: patients who received any adjuvant systemic therapy (chemotherapy, endocrine therapy and/or targeted therapy) and those who did not.</p>
<p id="Par24">Among nonrecipients, DFS did not differ significantly between AR-positive and AR-negative tumors (<em>P</em> = 0.104) (Fig. <a href="#Fig7" class="usa-link">7</a>A).</p>
<figure class="fig xbox font-sm" id="Fig7"><h4 class="obj_head">Fig. 7.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374384_40001_2025_3072_Fig7_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7a/12374384/ea126e6b50e2/40001_2025_3072_Fig7_HTML.jpg" loading="lazy" id="MO7" height="944" width="660" alt="Fig. 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Kaplan–Meier curve analysis of the disease-free survival according to AR expression in patients not receiving adjuvant therapy (7A).Kaplan–Meier curve analysis of the disease-free survival according to AR expression in patients receiving adjuvant therapy (7B)</p></figcaption></figure><p id="Par25">Among recipients, there was likewise no significant difference (<em>P</em> = 0.269) (Fig. <a href="#Fig7" class="usa-link">7</a>B).</p></section><section id="Sec17"><h3 class="pmc_sec_title">Subgroup analysis based on different expression levels of ER</h3>
<p id="Par26">To further clarify the impact of different expression levels of ER on survival, we classified ER into high ER expression (&gt; 10%), low ER expression (1–10%), and ER negative according to the ASCO/CAP guidelines (2020)[<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. The results showed that 332 patients (64.5%) were highly expressed, 25 patients (4.9%) were expressed, and 158 patients (30.7%) were negative. Kaplan–Meier curve analysis showed that individuals with high expression of ER had a better prognosis, followed by those with low expression. Patients with negative ER had the worst prognosis, and the results were statistically significant (<em>P</em> &lt; 0.05) (Fig. <a href="#Fig8" class="usa-link">8</a>).</p>
<figure class="fig xbox font-sm" id="Fig8"><h4 class="obj_head">Fig. 8.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374384_40001_2025_3072_Fig8_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7a/12374384/1f6061d46eb5/40001_2025_3072_Fig8_HTML.jpg" loading="lazy" id="MO8" height="532" width="780" alt="Fig. 8"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig8/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Kaplan–Meier curve analysis of the Subgroup analysis based on different expression levels of ER</p></figcaption></figure></section><section id="Sec18"><h3 class="pmc_sec_title">Relationship between AR/ER ratio and clinicopathological features</h3>
<p id="Par27">When ≥ 10% of tumor cell nuclei are stained with dark brown granules, it is defined as AR-positive. Similarly, when ≥ 1% of tumor cell nuclei are stained with brown granules, it is defined as ER positivity. Among the 333 ER-positive and AR-positive patients with breast cancer, an AR/ER ratio was calculated, with 21 patients (4.1%) exhibiting AR/ER ≥ 2. Among the 333 patients, a total of 13 patients were lacking TOPO-II data; 2 patients, P-53 data; 3 patients, CK5/6 data; 2 patients, EGFR data. Patients with breast cancer exhibiting an AR/ER ratio ≥ 2 and AR/ER ratio &lt; 2 had different ages, menstrual status, tumor size, regional lymph node metastasis, histological grade, tumor thrombus, nerve and vascular invasion, Ki-67 status,CK5/6, TOPO-II, and P-53 expression etc. were not statistically significant (<em>P</em> &gt; 0.05) (Table <a href="#Tab3" class="usa-link">3</a>).
</p>
<section class="tw xbox font-sm" id="Tab3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Relationship between AR/ER ratio and clinicopathological characteristics</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Variables</th>
<th align="left" colspan="1" rowspan="1">AR/ER &lt; 2 (n = 312)</th>
<th align="left" colspan="1" rowspan="1">AR/ER ≥ 2 (n = 21)</th>
<th align="left" colspan="1" rowspan="1">Statistic</th>
<th align="left" colspan="1" rowspan="1"><em>P</em></th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="3" rowspan="1">TOPO—2</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 0.01</td>
<td align="left" colspan="1" rowspan="1">0.927</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Negative</td>
<td align="center" colspan="1" rowspan="1">102 (34.00)</td>
<td align="center" colspan="1" rowspan="1">7 (35.00)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Positive</td>
<td align="center" colspan="1" rowspan="1">198 (66.00)</td>
<td align="center" colspan="1" rowspan="1">13 (65.00)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Age (years)</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 5.38</td>
<td align="left" colspan="1" rowspan="1">0.068</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  ≤ 35</td>
<td align="center" colspan="1" rowspan="1">17 (5.45)</td>
<td align="center" colspan="1" rowspan="1">3 (14.29)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 35–60</td>
<td align="center" colspan="1" rowspan="1">207 (66.35)</td>
<td align="center" colspan="1" rowspan="1">16 (76.19)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  &gt; 60</td>
<td align="center" colspan="1" rowspan="1">88 (28.21)</td>
<td align="center" colspan="1" rowspan="1">2 (9.52)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">BMI</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 4.57</td>
<td align="left" colspan="1" rowspan="1">0.102</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  &lt; 25</td>
<td align="center" colspan="1" rowspan="1">190 (60.90)</td>
<td align="center" colspan="1" rowspan="1">13 (61.90)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  ≥ 30</td>
<td align="center" colspan="1" rowspan="1">46 (14.74)</td>
<td align="center" colspan="1" rowspan="1">0 (0.00)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 25–29</td>
<td align="center" colspan="1" rowspan="1">76 (24.36)</td>
<td align="center" colspan="1" rowspan="1">8 (38.10)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Smoking</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 1.43</td>
<td align="left" colspan="1" rowspan="1">0.489</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Current</td>
<td align="center" colspan="1" rowspan="1">43 (13.78)</td>
<td align="center" colspan="1" rowspan="1">1 (4.76)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Never</td>
<td align="center" colspan="1" rowspan="1">89 (28.53)</td>
<td align="center" colspan="1" rowspan="1">7 (33.33)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Past</td>
<td align="center" colspan="1" rowspan="1">180 (57.69)</td>
<td align="center" colspan="1" rowspan="1">13 (61.90)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Benign breast disease</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 1.27</td>
<td align="left" colspan="1" rowspan="1">0.259</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="center" colspan="1" rowspan="1">281 (90.06)</td>
<td align="center" colspan="1" rowspan="1">21 (100.00)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="center" colspan="1" rowspan="1">31 (9.94)</td>
<td align="center" colspan="1" rowspan="1">0 (0.00)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Menstrual status</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 1.51</td>
<td align="left" colspan="1" rowspan="1">0.220</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Premenopausal</td>
<td align="center" colspan="1" rowspan="1">162 (51.92)</td>
<td align="center" colspan="1" rowspan="1">8 (38.10)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Menopausal</td>
<td align="center" colspan="1" rowspan="1">150 (48.08)</td>
<td align="center" colspan="1" rowspan="1">13 (61.90)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Tumor size (cm)</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 0.66</td>
<td align="left" colspan="1" rowspan="1">0.717</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  ≤ 2</td>
<td align="center" colspan="1" rowspan="1">135 (43.27)</td>
<td align="center" colspan="1" rowspan="1">11 (52.38)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  &gt; 2</td>
<td align="center" colspan="1" rowspan="1">160 (51.28)</td>
<td align="center" colspan="1" rowspan="1">9 (42.86)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Lymph node metastasis</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">0.325</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> N0</td>
<td align="center" colspan="1" rowspan="1">189 (60.58)</td>
<td align="center" colspan="1" rowspan="1">13 (61.90)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> N1</td>
<td align="center" colspan="1" rowspan="1">73 (23.40)</td>
<td align="center" colspan="1" rowspan="1">4 (19.05)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> N2</td>
<td align="center" colspan="1" rowspan="1">34 (10.90)</td>
<td align="center" colspan="1" rowspan="1">1 (4.76)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> N3</td>
<td align="center" colspan="1" rowspan="1">16 (5.13)</td>
<td align="center" colspan="1" rowspan="1">3 (14.29)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Histological grading</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">0.596</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 1–2​</td>
<td align="center" colspan="1" rowspan="1">19 (6.09)</td>
<td align="center" colspan="1" rowspan="1">0 (0.00)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 3</td>
<td align="center" colspan="1" rowspan="1">236 (75.64)</td>
<td align="center" colspan="1" rowspan="1">16 (76.19)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">PR</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 25.68</td>
<td align="left" colspan="1" rowspan="1"> &lt;.001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Negative</td>
<td align="center" colspan="1" rowspan="1">17 (5.45)</td>
<td align="center" colspan="1" rowspan="1">8 (38.10)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Positive</td>
<td align="center" colspan="1" rowspan="1">295 (94.55)</td>
<td align="center" colspan="1" rowspan="1">13 (61.90)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">KI67</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 0.00</td>
<td align="left" colspan="1" rowspan="1">1.000</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  &lt; 14%</td>
<td align="center" colspan="1" rowspan="1">42 (13.46)</td>
<td align="center" colspan="1" rowspan="1">3 (14.29)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  ≥ 14%</td>
<td align="center" colspan="1" rowspan="1">270 (86.54)</td>
<td align="center" colspan="1" rowspan="1">18 (85.71)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">HER2</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 6.39</td>
<td align="left" colspan="1" rowspan="1">0.011</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Negative</td>
<td align="center" colspan="1" rowspan="1">246 (78.85)</td>
<td align="center" colspan="1" rowspan="1">11 (52.38)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Positive</td>
<td align="center" colspan="1" rowspan="1">66 (21.15)</td>
<td align="center" colspan="1" rowspan="1">10 (47.62)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">P53</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 3.66</td>
<td align="left" colspan="1" rowspan="1">0.056</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Negative</td>
<td align="center" colspan="1" rowspan="1">170 (54.84)</td>
<td align="center" colspan="1" rowspan="1">7 (33.33)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Positive</td>
<td align="center" colspan="1" rowspan="1">140 (45.16)</td>
<td align="center" colspan="1" rowspan="1">14 (66.67)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">CK56</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 1.56</td>
<td align="left" colspan="1" rowspan="1">0.212</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Negative</td>
<td align="center" colspan="1" rowspan="1">283 (91.59)</td>
<td align="center" colspan="1" rowspan="1">17 (80.95)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Positive</td>
<td align="center" colspan="1" rowspan="1">26 (8.41)</td>
<td align="center" colspan="1" rowspan="1">4 (19.05)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">EGFR</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 9.32</td>
<td align="left" colspan="1" rowspan="1">0.002</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Negative</td>
<td align="center" colspan="1" rowspan="1">281 (90.65)</td>
<td align="center" colspan="1" rowspan="1">14 (66.67)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Positive</td>
<td align="center" colspan="1" rowspan="1">29 (9.35)</td>
<td align="center" colspan="1" rowspan="1">7 (33.33)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Vascular invasion</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 0.05</td>
<td align="left" colspan="1" rowspan="1">0.830</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="center" colspan="1" rowspan="1">280 (89.74)</td>
<td align="center" colspan="1" rowspan="1">18 (85.71)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="center" colspan="1" rowspan="1">32 (10.26)</td>
<td align="center" colspan="1" rowspan="1">3 (14.29)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Nerve invasion</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 0.09</td>
<td align="left" colspan="1" rowspan="1">0.764</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="center" colspan="1" rowspan="1">267 (85.58)</td>
<td align="center" colspan="1" rowspan="1">19 (90.48)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="center" colspan="1" rowspan="1">45 (14.42)</td>
<td align="center" colspan="1" rowspan="1">2 (9.52)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Cancer thrombus</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">0.483</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="center" colspan="1" rowspan="1">303 (97.12)</td>
<td align="center" colspan="1" rowspan="1">20 (95.24)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="center" colspan="1" rowspan="1">9 (2.88)</td>
<td align="center" colspan="1" rowspan="1">1 (4.76)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p41"><p>Data in brackets represent the percentages of patients. TOPO-2: Topoisomerase-2; <em>AR</em> Androgen receptor; <em>EGFR</em> Epidermal growth factor receptor; <em>ER</em> Estrogen receptor; <em>HER-2</em> Human epidermal growth factor receptor-2; <em>HR</em> Hormone receptor; <em>PR</em> Progesterone receptor</p></div></div></section></section><section id="Sec19"><h3 class="pmc_sec_title">The significance of AR/ER ratio in ER-positive/AR-positive invasive breast cancer</h3>
<p id="Par28">In the subset of 333 ER-positive and AR-positive patients with breast cancer, the 5-year DFS rate of patients with AR/ER ratio ≥ 2 was 61.9%, whereas that of those with AR/ER ratio &lt; 2 was 88.5%. Comparison of the 5-year DFS curves of the two groups revealed a significantly better prognosis in the AR/ER ratio &lt; 2 group compared to the AR/ER ratio ≥ 2 group (Log Rank test <em>P</em> &lt; 0.001) (Fig. <a href="#Fig9" class="usa-link">9</a>).</p>
<figure class="fig xbox font-sm" id="Fig9"><h4 class="obj_head">Fig. 9.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374384_40001_2025_3072_Fig9_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7a/12374384/ce2a04e55972/40001_2025_3072_Fig9_HTML.jpg" loading="lazy" id="MO9" height="531" width="780" alt="Fig. 9"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig9/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Kaplan–Meier curve analysis of the relationship between AR/ER ratio and disease-free survival in ER-positive/AR-positive breast cancer</p></figcaption></figure></section><section id="Sec20"><h3 class="pmc_sec_title">Univariate and multivariate analyses of DFS in patients with ER-positive/AR-positive invasive breast cancer</h3>
<p id="Par29">After excluding patients with incomplete data, univariate analysis using the Cox regression risk model on 317 ER-positive and AR-positive patients with breast cancer identified AR/ER ratio [3.61(1.60–8.13)], histological classification [5.06(2.76–9.28)], and lymph node metastasis [3.17(1.68–5.96)] as prognostic factors (<em>P</em> &lt; 0.05). In multivariate analysis, AR/ER ratio [3.42(1.50–7.77)], histological classification [4.14(2.23–7.67)], and lymph node metastasis [2.79(1.47–5.30)] were independent prognostic factors affecting DFS in patients with ER-positive/AR-positive invasive breast cancer (<em>P</em> &lt; 0.05) (Table <a href="#Tab4" class="usa-link">4</a>). Utilizing these independent prognostic factors, nomogram prediction models for 1-year, 3-year, and 5-year DFS (Fig. <a href="#Fig10" class="usa-link">10</a>). The C-index for the nomogram model training set was 0.7468, and for the validation set, it was 0.7205.
</p>
<section class="tw xbox font-sm" id="Tab4"><h4 class="obj_head">Table 4.</h4>
<div class="caption p"><p>Univariate and multivariate analyses of the prognostic factors for progression-free survival</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1">Factors</th>
<th align="left" colspan="2" rowspan="1">Univariate</th>
<th align="left" colspan="2" rowspan="1">Multivariate</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1"><em>HR (95% CI)</em></th>
<th align="left" colspan="1" rowspan="1"><em>P</em></th>
<th align="left" colspan="1" rowspan="1"><em>HR (95% CI)</em></th>
<th align="left" colspan="1" rowspan="1"><em>P</em></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">TOPO—2</td>
<td align="left" colspan="1" rowspan="1">1.35(0.69–2.64)</td>
<td align="center" colspan="1" rowspan="1">0.378</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="center" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Age (≤ 35 VS 35–60 years)</td>
<td align="left" colspan="1" rowspan="1">0.75(0.23–2.47)</td>
<td align="center" colspan="1" rowspan="1">0.635</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="center" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Age (≤ 35 VS &gt; 60) years</td>
<td align="left" colspan="1" rowspan="1">1.01(0.29–3.55)</td>
<td align="center" colspan="1" rowspan="1">0.987</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="center" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">BMI(&lt; 25 VS ≥ 30)</td>
<td align="left" colspan="1" rowspan="1">0.92(0.44–1.93)</td>
<td align="center" colspan="1" rowspan="1">0.822</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="center" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">BMI(&lt; 25 VS 25–29)</td>
<td align="left" colspan="1" rowspan="1">0.92 (0.44–1.93)</td>
<td align="center" colspan="1" rowspan="1">0.831</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="center" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Smoking(Current VS Never)</td>
<td align="left" colspan="1" rowspan="1">0.67 (0.29–1.54)</td>
<td align="center" colspan="1" rowspan="1">0.343</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="center" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Smoking(Current VS Past)</td>
<td align="left" colspan="1" rowspan="1">0.88 (0.45–1.73)</td>
<td align="center" colspan="1" rowspan="1">0.709</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="center" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Benign breast disease</td>
<td align="left" colspan="1" rowspan="1">1.50 (0.46–4.84)</td>
<td align="center" colspan="1" rowspan="1">0.501</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="center" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Menstruation</td>
<td align="left" colspan="1" rowspan="1">1.25(0.68–2.29)</td>
<td align="center" colspan="1" rowspan="1">0.472</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="center" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Size</td>
<td align="left" colspan="1" rowspan="1">1.33(0.71–2.47)</td>
<td align="center" colspan="1" rowspan="1">0.373</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="center" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">LN metastasis</td>
<td align="left" colspan="1" rowspan="1">3.17(1.68–5.96)</td>
<td align="center" colspan="1" rowspan="1"> &lt; 0.001</td>
<td align="left" colspan="1" rowspan="1">2.79(1.47–5.30)</td>
<td align="center" colspan="1" rowspan="1">0.002</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Organizational</td>
<td align="left" colspan="1" rowspan="1">5.06(2.76–9.28)</td>
<td align="center" colspan="1" rowspan="1"> &lt; 0.001</td>
<td align="left" colspan="1" rowspan="1">4.14(2.23–7.67)</td>
<td align="center" colspan="1" rowspan="1"> &lt; 0.001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Luminal (Luminal A VS HER 2 +, HR +)</td>
<td align="left" colspan="1" rowspan="1">1.31 (0.27–6.51)</td>
<td align="center" colspan="1" rowspan="1">0.738</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="center" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Luminal (Luminal A VS Luminal B, HER 2-)</td>
<td align="left" colspan="1" rowspan="1">2.50(0.60–10.41)</td>
<td align="center" colspan="1" rowspan="1">0.208</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="center" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Typing</td>
<td align="left" colspan="1" rowspan="1">1.49(0.66–3.36)</td>
<td align="center" colspan="1" rowspan="1">0.332</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="center" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ARER</td>
<td align="left" colspan="1" rowspan="1">3.61(1.60–8.13)</td>
<td align="center" colspan="1" rowspan="1">0.002</td>
<td align="left" colspan="1" rowspan="1">3.42(1.50–7.77)</td>
<td align="center" colspan="1" rowspan="1">0.003</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PR</td>
<td align="left" colspan="1" rowspan="1">0.75(0.27–2.11)</td>
<td align="center" colspan="1" rowspan="1">0.587</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="center" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">KI67</td>
<td align="left" colspan="1" rowspan="1">2.01(0.62–6.50)</td>
<td align="center" colspan="1" rowspan="1">0.245</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="center" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HER2</td>
<td align="left" colspan="1" rowspan="1">0.67(0.30–1.51)</td>
<td align="center" colspan="1" rowspan="1">0.332</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="center" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">P53</td>
<td align="left" colspan="1" rowspan="1">0.70(0.38–1.30)</td>
<td align="center" colspan="1" rowspan="1">0.260</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="center" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CK56</td>
<td align="left" colspan="1" rowspan="1">1.14(0.41–3.21)</td>
<td align="center" colspan="1" rowspan="1">0.797</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="center" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">EGFR</td>
<td align="left" colspan="1" rowspan="1">0.86(0.31–2.41)</td>
<td align="center" colspan="1" rowspan="1">0.775</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="center" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Vasculature</td>
<td align="left" colspan="1" rowspan="1">1.44(0.61–3.43)</td>
<td align="center" colspan="1" rowspan="1">0.405</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="center" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Nerve</td>
<td align="left" colspan="1" rowspan="1">0.98(0.41–2.32)</td>
<td align="center" colspan="1" rowspan="1">0.955</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="center" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cancer thrombus</td>
<td align="left" colspan="1" rowspan="1">0.76(0.11–5.55)</td>
<td align="center" colspan="1" rowspan="1">0.789</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="center" colspan="1" rowspan="1">–</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p46"><p>Data in brackets represent the percentages of patients. <em>TOPO-2</em> Topoisomerase-2; <em>AR</em> Androgen receptor; <em>EGFR</em> Epidermal growth factor receptor; <em>ER</em> Estrogen receptor; <em>HER-2</em> Human epidermal growth factor receptor-2; <em>HR</em> Hormone receptor; <em>PR</em> Progesterone receptor</p></div></div></section><figure class="fig xbox font-sm" id="Fig10"><h4 class="obj_head">Fig. 10.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374384_40001_2025_3072_Fig10_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7a/12374384/93c77c9fd5a2/40001_2025_3072_Fig10_HTML.jpg" loading="lazy" id="MO10" height="257" width="778" alt="Fig. 10"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig10/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Graph depicting the prognostic model for predicting 1-, 3-, and 5-year disease-free survival</p></figcaption></figure></section><section id="Sec21"><h3 class="pmc_sec_title">Validation of prognostic models</h3>
<p id="Par30">Patients were randomly assigned to the training dataset (<em>n</em> = 222) and internal validation dataset (<em>n</em> = 95) in a 7:3 ratio. The baseline characteristics of both datasets are shown in Table <a href="#Tab5" class="usa-link">5</a>. The AUCs for 1-year DFS in the training set and internal validation set were 0.753 and 0.877, respectively; for 3-year DFS, they were 0.799 and 0.976; and for 5-year DFS, they were 0.767 and 0.719, respectively (Fig. <a href="#Fig11" class="usa-link">11</a>A–<a href="#Fig9" class="usa-link">9</a>F). Subsequently, calibration curves for 1, 3, and 5 years showed that the model-predicted risk was consistent with the actual occurrence of risk (Fig. <a href="#Fig12" class="usa-link">12</a>A–<a href="#Fig10" class="usa-link">10</a>F).
</p>
<section class="tw xbox font-sm" id="Tab5"><h4 class="obj_head">Table 5.</h4>
<div class="caption p"><p>Patient characteristics of the training and validation sets</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Characteristic</th>
<th align="left" colspan="1" rowspan="1">Training Cohort (n = 222)</th>
<th align="left" colspan="1" rowspan="1">Internal Test Cohort(n = 95)</th>
<th align="left" colspan="1" rowspan="1">Statistic</th>
<th align="left" colspan="1" rowspan="1"><em>P</em></th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="3" rowspan="1">TOPO—2</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 1.44</td>
<td align="center" colspan="1" rowspan="1">0.231</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Negative</td>
<td align="center" colspan="1" rowspan="1">71 (32%)</td>
<td align="center" colspan="1" rowspan="1">37 (39%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Positive</td>
<td align="center" colspan="1" rowspan="1">151 (68%)</td>
<td align="center" colspan="1" rowspan="1">58 (61%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Age (years)</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 0.98</td>
<td align="center" colspan="1" rowspan="1">0.612</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  ≤ 35</td>
<td align="center" colspan="1" rowspan="1">15 (6.8%)</td>
<td align="center" colspan="1" rowspan="1">4 (4.2%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 35–60</td>
<td align="center" colspan="1" rowspan="1">147 (66%)</td>
<td align="center" colspan="1" rowspan="1">67 (71%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  &gt; 60</td>
<td align="center" colspan="1" rowspan="1">60 (27%)</td>
<td align="center" colspan="1" rowspan="1">24 (25%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">BMI</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 0.13</td>
<td align="center" colspan="1" rowspan="1">0.938</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  &lt; 25</td>
<td align="center" colspan="1" rowspan="1">71 (31.98)</td>
<td align="center" colspan="1" rowspan="1">29 (30.53)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  ≥ 30</td>
<td align="center" colspan="1" rowspan="1">75 (33.78)</td>
<td align="center" colspan="1" rowspan="1">34 (35.79)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 25–29</td>
<td align="center" colspan="1" rowspan="1">76 (34.23)</td>
<td align="center" colspan="1" rowspan="1">32 (33.68)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Smoking</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 8.70</td>
<td align="center" colspan="1" rowspan="1">0.013</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Current</td>
<td align="center" colspan="1" rowspan="1">73 (32.88)</td>
<td align="center" colspan="1" rowspan="1">47 (49.47)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Never</td>
<td align="center" colspan="1" rowspan="1">62 (27.93)</td>
<td align="center" colspan="1" rowspan="1">16 (16.84)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Past</td>
<td align="center" colspan="1" rowspan="1">87 (39.19)</td>
<td align="center" colspan="1" rowspan="1">32 (33.68)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Benign breast disease</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 0.16</td>
<td align="center" colspan="1" rowspan="1">0.693</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="center" colspan="1" rowspan="1">212 (95.50)</td>
<td align="center" colspan="1" rowspan="1">89 (93.68)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="center" colspan="1" rowspan="1">10 (4.50)</td>
<td align="center" colspan="1" rowspan="1">6 (6.32)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Menstrual status</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 0.04</td>
<td align="center" colspan="1" rowspan="1">0.834</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Premenopausal</td>
<td align="center" colspan="1" rowspan="1">114 (51%)</td>
<td align="center" colspan="1" rowspan="1">50 (53%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Menopausal</td>
<td align="center" colspan="1" rowspan="1">108 (49%)</td>
<td align="center" colspan="1" rowspan="1">45 (47%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Tumor size (cm)</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 0.06</td>
<td align="center" colspan="1" rowspan="1">0.813</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  ≤ 2</td>
<td align="center" colspan="1" rowspan="1">99 (45%)</td>
<td align="center" colspan="1" rowspan="1">41 (43%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  &gt; 2</td>
<td align="center" colspan="1" rowspan="1">123 (55%)</td>
<td align="center" colspan="1" rowspan="1">54 (57%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Lymph nodes metastasis</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 5.63</td>
<td align="center" colspan="1" rowspan="1">0.018</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="center" colspan="1" rowspan="1">125 (56.31)</td>
<td align="center" colspan="1" rowspan="1">67 (70.53)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="center" colspan="1" rowspan="1">97 (43.69)</td>
<td align="center" colspan="1" rowspan="1">28 (29.47)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Histological grading</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 0.78</td>
<td align="center" colspan="1" rowspan="1">0.376</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 1–2</td>
<td align="center" colspan="1" rowspan="1">175 (78.83)</td>
<td align="center" colspan="1" rowspan="1">79 (83.16)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 3</td>
<td align="center" colspan="1" rowspan="1">47 (21.17)</td>
<td align="center" colspan="1" rowspan="1">16 (16.84)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Typing</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 0.07</td>
<td align="center" colspan="1" rowspan="1">0.798</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> ER + HER + </td>
<td align="center" colspan="1" rowspan="1">52 (23%)</td>
<td align="center" colspan="1" rowspan="1">21 (22%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> ER + HER2-</td>
<td align="center" colspan="1" rowspan="1">170 (77%)</td>
<td align="center" colspan="1" rowspan="1">74 (78%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">AR/ER</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 1.02</td>
<td align="center" colspan="1" rowspan="1">0.312</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  &lt; 2</td>
<td align="center" colspan="1" rowspan="1">210 (95%)</td>
<td align="center" colspan="1" rowspan="1">87 (92%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  ≥ 2</td>
<td align="center" colspan="1" rowspan="1">12 (5.4%)</td>
<td align="center" colspan="1" rowspan="1">8 (8.4%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">PR</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 0.31</td>
<td align="center" colspan="1" rowspan="1">0.581</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Negative</td>
<td align="center" colspan="1" rowspan="1">18 (8.1%)</td>
<td align="center" colspan="1" rowspan="1">6 (6.3%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Positive</td>
<td align="center" colspan="1" rowspan="1">204 (92%)</td>
<td align="center" colspan="1" rowspan="1">89 (94%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">KI67</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 1.44</td>
<td align="center" colspan="1" rowspan="1">0.230</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  &lt; 14%</td>
<td align="center" colspan="1" rowspan="1">32 (14%)</td>
<td align="center" colspan="1" rowspan="1">9 (9.5%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  ≥ 14%</td>
<td align="center" colspan="1" rowspan="1">190 (86%)</td>
<td align="center" colspan="1" rowspan="1">86 (91%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">HER2</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 0.07</td>
<td align="center" colspan="1" rowspan="1">0.798</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Negative</td>
<td align="center" colspan="1" rowspan="1">170 (77%)</td>
<td align="center" colspan="1" rowspan="1">74 (78%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Positive</td>
<td align="center" colspan="1" rowspan="1">52 (23%)</td>
<td align="center" colspan="1" rowspan="1">21 (22%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">P53</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 2.14</td>
<td align="center" colspan="1" rowspan="1">0.144</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Negative</td>
<td align="center" colspan="1" rowspan="1">125 (56%)</td>
<td align="center" colspan="1" rowspan="1">45 (47%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Positive</td>
<td align="center" colspan="1" rowspan="1">97 (44%)</td>
<td align="center" colspan="1" rowspan="1">50 (53%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">CK56</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 1.84</td>
<td align="center" colspan="1" rowspan="1">0.175</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Negative</td>
<td align="center" colspan="1" rowspan="1">200 (90%)</td>
<td align="center" colspan="1" rowspan="1">90 (95%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Positive</td>
<td align="center" colspan="1" rowspan="1">22 (9.9%)</td>
<td align="center" colspan="1" rowspan="1">5 (5.3%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">EGFR</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 1.60</td>
<td align="center" colspan="1" rowspan="1">0.206</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Negative</td>
<td align="center" colspan="1" rowspan="1">195 (88%)</td>
<td align="center" colspan="1" rowspan="1">88 (93%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Positive</td>
<td align="center" colspan="1" rowspan="1">27 (12%)</td>
<td align="center" colspan="1" rowspan="1">7 (7.4%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Vasculature</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 0.35</td>
<td align="center" colspan="1" rowspan="1">0.554</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="center" colspan="1" rowspan="1">199 (90%)</td>
<td align="center" colspan="1" rowspan="1">83 (87%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="center" colspan="1" rowspan="1">23 (10%)</td>
<td align="center" colspan="1" rowspan="1">12 (13%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Nerve</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 2.88</td>
<td align="center" colspan="1" rowspan="1">0.090</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="center" colspan="1" rowspan="1">194 (87%)</td>
<td align="center" colspan="1" rowspan="1">76 (80%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="center" colspan="1" rowspan="1">28 (13%)</td>
<td align="center" colspan="1" rowspan="1">19 (20%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Cancer thrombus</td>
<td align="center" colspan="1" rowspan="1">χ<sup>2</sup> = 0.12</td>
<td align="center" colspan="1" rowspan="1">0.729</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="center" colspan="1" rowspan="1">214 (96%)</td>
<td align="center" colspan="1" rowspan="1">93 (98%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="center" colspan="1" rowspan="1">8 (3.6%)</td>
<td align="center" colspan="1" rowspan="1">2 (2.1%)</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p50"><p>Data in brackets represent the percentages of patients. <em>TOPO-2</em> Topoisomerase-2; <em>AR</em> Androgen receptor; <em>EGFR</em> Epidermal growth factor receptor; <em>ER</em> Estrogen receptor; <em>HER-2</em> Human epidermal growth factor receptor-2; <em>HR</em> Hormone receptor; <em>PR</em> Progesterone receptor</p></div></div></section><figure class="fig xbox font-sm" id="Fig11"><h4 class="obj_head">Fig. 11.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374384_40001_2025_3072_Fig11_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7a/12374384/02cea58b3999/40001_2025_3072_Fig11_HTML.jpg" loading="lazy" id="MO11" height="257" width="784" alt="Fig. 11"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig11/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Graphs depicting the ROC evaluation plot the 1-year prognostic prediction model’s (<strong>A</strong>) training set and (<strong>B</strong>) validation set; for the 3-year prognostic prediction model’s (<strong>C</strong>) training set and (<strong>D</strong>) the validation set; for the 5-year prognostic prediction model’s (<strong>E</strong>) training set and (<strong>F</strong>) validation set</p></figcaption></figure><figure class="fig xbox font-sm" id="Fig12"><h4 class="obj_head">Fig. 12.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374384_40001_2025_3072_Fig12_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7a/12374384/87961180bd3c/40001_2025_3072_Fig12_HTML.jpg" loading="lazy" id="MO12" height="254" width="784" alt="Fig. 12"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig12/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Calibration plots depicting the 1-year disease-free survival for the (<strong>A</strong>) training set and (<strong>B</strong>) validation set; that depicting the 3-year disease-free survival for the (<strong>C</strong>) training set and (<strong>D</strong>) validation set; that depicting the 5-year disease-free survival for the (<strong>E</strong>) training set and (<strong>F</strong>) validation set</p></figcaption></figure></section></section><section id="Sec22"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par31">In 2020, breast cancer surpassed lung cancer for the first time, becoming the most common cancer globally. With its high morbidity and mortality rates, it is also the primary health threat to women [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. Molecular markers such as ER, PR, and HER-2 play pivotal roles in breast cancer prognosis and guide targeted and endocrine therapies. AR, akin to ER and PR as a steroid hormone receptor, exhibits high expression in breast cancer, garnering attention as a prognostic indicator and treatment target. However, the association between AR and breast cancer prognosis remains inconclusive, warranting further in-depth study.</p>
<p id="Par32">The prevalence of AR-positive expression in patients with breast cancer varies greatly. A meta-analysis [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>] reported AR-positive tumors in 28–84% of breast cancers, reflecting disparities possibly attributed to factors population, detection methods, and AR positivity definitions. This underscores differential AR expression across races, potentially linked to varying proportions of breast cancer molecular subtypes. At present, immunohistochemical method and AR mRNA expression measurement are mainly used to detect the expression of AR in breast cancer, of which immunohistochemical method is the most commonly used because of its economic applicability. In addition, most studies use a 10% threshold to define AR positivity, while a few studies use 1%, 5%, 35%, 45%, or 78% [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>, <a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>–<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>]. The detection method used in this study is the most commonly used immunohistochemical method, so we used the same commonly used 10% as the critical value for AR positivity [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. However, some studies have reported that the positive expression rate of AR is mostly between 70 and 85% [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>, <a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. Herein, we statistically analyzed the clinicopathological data of 515 female patients with unilateral invasive breast cancer post-modified radical surgery, revealing an AR-positive rate of 83.3% (429/515), consistent with previous reports. Moreover, the positive rates of ER and PR were 69.3% (357/515) and 64.3% (331/515), respectively. The positive rate of AR was significantly higher than that of ER and PR, consistent with Bronte's study [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. The expression status of AR correlates with certain clinicopathological parameters. Additionally, there were differences between the AR-positive group and the AR-negative group in terms of age, tumor size, menstrual status, lymph node metastasis, presence of tumor thrombus, nerve and vascular invasion, and expression of HER-2, Ki-67, and P-53; however, they were not statistically significant (<em>P</em> &gt; 0.05). There was likewise no significant difference in AR expression status across histological subtypes. Apocrine carcinoma, recognized as a histological subtype with a relatively favorable prognosis, was observed in only five cases in this study, accounting for an extremely low proportion—consistent with its biological rarity. This minimal representation precludes any meaningful impact on the overall patient prognosis. Furthermore, survival analysis using the Kaplan–Meier method demonstrated a significantly better prognosis in the AR-positive group as compared to the AR-negative group, underscoring AR’s potential prognostic value in breast (LogRank test <em>P</em> = 0.004).</p>
<p id="Par33">Preclinical studies suggest AR’s mechanism of action is linked to ER and HER-2 expression status [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. In this study, breast cancer was divided into four groups based on the ER and HER-2 expression for further investigation. In the ER (+)/HER-2(−), ER(+)/HER-2(+), ER(−)/HER-2(+), and ER(−)/HER-2(−) groups, the AR expression rates were 93.8%, 91.6%, 79.1%, and 38.9%, respectively, with statistically significant differences (<em>P</em> &lt; 0.001).</p>
<p id="Par34">Lanzino et al. [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>] found that in transiently transfected HeLa cells, the steroid receptor coactivator ARA70 binds to ERα when ERα: AR = 5:1; conversely, when ERα:AR = 1:5, ARA70 binds to AR, activating the AR signaling pathway and promoting cell proliferation. Thus, the AR/ER ratio reflects the crosstalk between these receptors. When AR is highly expressed and ERα is low, AR may promote cell proliferation instead of inhibiting estrogen-mediated breast cancer cell growth, underscoring the importance of the AR/ER ratio in breast cancer biology.</p>
<p id="Par35">Subsequent research [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>, <a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>, <a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>] has consistently suggested a worse prognosis for patients with a high AR/ER ratio, emphasizing its predictive role in ER-positive breast cancer prognosis.</p>
<p id="Par36">This study calculates the AR/ER ratio for 317 patients with breast cancer who are ER positive and AR positive. Given that multiple studies have used ROC analysis to demonstrate that an AR/ER ratio of 2 is the optimal cutoff value [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>, <a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>], this study divided 333 patients into groups with AR/ER ratios ≥ 2 and AR/ER ratios &lt; 2 to explore their relationship with clinical and pathological features. It revealed a high AR/ER ratio (≥ 2) in cases where HER-2 was positive, EGFR was positive, and PR was negative, with statistically significant differences (<em>P</em> &lt; 0.05). However, no statistically significant differences were observed between patients with AR/ER ratio ≥ 2 and AR/ER ratio ≤ 2 in terms of age, menstrual status, tumor size, regional lymph node metastasis, histological grade, tumor thrombus, nerve and vessel invasion, and Ki-67, CK5/6, TOPO-II, and P-53 levels (<em>P</em> &gt; 0.05). In addition, the 5-year DFS rate of patients with an AR/ER ratio ≥ 2 was significantly lower than that of the AR/ER ratio &lt; 2 group (<em>P</em> &lt; 0.05). Multivariable Cox proportional hazards regression analysis identified histological type, AR/ER ratio, and lymph node metastasis as independent prognostic factors for DFS. A nomogram prediction model incorporating these independent risk factors illustrated histological classification’s greatest impact on DFS, with lymph node metastasis exerting the least impact on DFS. Additionally, we calculated the c-index and plotted a calibration curve to validate the nomogram prediction model. The C-index of the nomogram model training and validation sets were 0.7468 and 0.7205, respectively. Moreover, the calibration curve shows that our model agrees well with the actual observations, illustrating the reliability and accuracy of our model.</p>
<p id="Par37">The AR/ER ratio emerges as a potential independent predictor of response to conventional endocrine therapies targeting estrogen and ER signaling pathways. While AR expression is generally associated with a favorable prognosis in ER-positive breast cancer, immunohistochemical assessment of AR and ER expression levels, especially the AR/ER ratio, can enhance prognostic prediction and therapeutic response to hormonal therapy in invasive breast cancer. The previous failure of AR antagonists in the treatment of breast cancer might stem from overlooking the unique significance of the AR/ER ratio in ER-positive breast cancer. Consequently, the AR/ER ratio introduced novel considerations for breast cancer therapy, especially in addressing endocrine resistance among ER-positive/AR-positive breast cancer patients with an AR/ER ratio ≥ 2, who might benefit from AR-targeted therapy.</p>
<p id="Par38">As a retrospective study, the research results will be influenced by the accuracy and completeness of data collection. In addition, all specimens in this study were tested using immunohistochemistry, which has significant differences in sensitivity and specificity as compared to other detection methods, which may cause bias in the results. Notably, in the cohort of 317 ER-positive and AR-positive patients with breast cancer, HER-2 failed to emerge as a significant prognostic factor, likely attributable to the high proportion of anti-HER-2 treatment among included patients. Similarly, the significance of Ki-67 as a prognostic factor may stem from the small number of patients with low Ki-67 expression and the study’s utilization of 14% as the cutoff value; additionally, inter-reader variability in Ki-67 values underscores the need for meticulous evaluation in future studies [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>, <a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>].</p>
<p id="Par39">Furthermore, apocrine breast carcinoma accounts for only about 1% of all breast cancers, and the five apocrine cases identified in our cohort were insufficient for a separate subgroup analysis. Detailed records of specific adjuvant systemic regimens (e.g., chemotherapy protocols, endocrine agents, or HER2-targeted therapies) were not uniformly available; therefore, we could only stratify outcomes by “any” versus “no” adjuvant treatment, which limits the precision of prognostic interpretations. Lastly, the study population was limited to patients who underwent upfront modified radical mastectomy without neoadjuvant therapy; thus, whether our findings can be generalized to patients receiving neoadjuvant systemic therapy or breast-conserving surgery requires further validation. Future investigations should also explore the differential efficacy of anti-AR therapies across distinct AR-positive breast cancer subtypes.</p></section><section id="Sec23"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par40">This study suggests that an AR/ER ratio ≥ 2 serves as an indicator of adverse prognosis in ER-positive/AR-positive breast cancer. However, it is important to note that our study is based on non-randomized retrospective observational data, offering limited evidence on the efficacy and safety of therapeutic interventions. Therefore, these findings should not be solely relied upon for clinical decisions without further evidence-based confirmation. Future prospective studies featuring extended follow-up periods and larger sample sizes are imperative to validate our findings and furnish stronger evidence for clinical decision-making.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>Not applicable</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>L and H designed the study. C. P and L collected the clinical data. C. P. L. P. P.Y and Z analyzed the data. P.L.W. B.Y.P.Z and G wrote the paper. C.P.L and Y revised the paper. All authors contributed to the article and approved the submitted version.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>No grant numbers apply.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>No datasets were generated or analysed during the current study.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par41">This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Affiliated Hospital of Xuzhou Medical University (XYFY2022-KL321). Due to the retrospective nature of this study, with the approval of the Ethics Committee of Xuzhou Medical University Affiliated Hospital, we waived the requirement for written informed consent.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par42">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par43">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1">
<p><strong>Publisher's Note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div>
<div class="fn p" id="fn2"><p>Menghan Cao, Di Pan and Yuqi Li are Co-first authors.</p></div>
</div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Haonan Liu, Email: why974300@163.com.</p>
<p>Zhengxiang Han, Email: cnhzxyq@163.com.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Chen J, Hao L, Qian X, et al. Machine learning models based on immunological genes to predict the response to neoadjuvant therapy in breast cancer patients. Front Immunol. 2022;13: 948601. 10.3389/fimmu.2022.948601.
</cite> [<a href="https://doi.org/10.3389/fimmu.2022.948601" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9352856/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35935976/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20J,%20Hao%20L,%20Qian%20X,%20et%20al.%20Machine%20learning%20models%20based%20on%20immunological%20genes%20to%20predict%20the%20response%20to%20neoadjuvant%20therapy%20in%20breast%20cancer%20patients.%20Front%20Immunol.%202022;13:%20948601.%2010.3389/fimmu.2022.948601." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Zhang J, Zhang Y, Li L, et al. Pregnancy-associated plasma protein-A (PAPPA) promotes breast cancer progression. Bioengineered. 2022;13(1):291–307. 10.1080/21655979.2021.2000724.
</cite> [<a href="https://doi.org/10.1080/21655979.2021.2000724" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8805841/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34974815/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20J,%20Zhang%20Y,%20Li%20L,%20et%20al.%20Pregnancy-associated%20plasma%20protein-A%20(PAPPA)%20promotes%20breast%20cancer%20progression.%20Bioengineered.%202022;13(1):291%E2%80%93307.%2010.1080/21655979.2021.2000724." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Chen QF, Chang L, Su Q, et al. Clinical importance of serum secreted clusterin in predicting invasive breast cancer and treatment responses. Bioengineered. 2021;12(1):278–85. 10.1080/21655979.2020.1868732.
</cite> [<a href="https://doi.org/10.1080/21655979.2020.1868732" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8806267/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33356806/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20QF,%20Chang%20L,%20Su%20Q,%20et%20al.%20Clinical%20importance%20of%20serum%20secreted%20clusterin%20in%20predicting%20invasive%20breast%20cancer%20and%20treatment%20responses.%20Bioengineered.%202021;12(1):278%E2%80%9385.%2010.1080/21655979.2020.1868732." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Itani N, Grogan N, Mott S, et al. Metastatic presentations of previously treated early-stage breast cancer patients and association with survival. Clin Breast Cancer. 2019;3(S1526–8209):30735–9. 10.1016/j.clbc.2019.11.004.</cite> [<a href="https://doi.org/10.1016/j.clbc.2019.11.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32007466/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Itani%20N,%20Grogan%20N,%20Mott%20S,%20et%20al.%20Metastatic%20presentations%20of%20previously%20treated%20early-stage%20breast%20cancer%20patients%20and%20association%20with%20survival.%20Clin%20Breast%20Cancer.%202019;3(S1526%E2%80%938209):30735%E2%80%939.%2010.1016/j.clbc.2019.11.004." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Skuli SJ, Sheng JY, Bantug ET, et al. Survivorship care visits in a high-risk population of breast cancer survivors. Breast Cancer Res Treat. 2019;173(3):701–8.
</cite> [<a href="https://doi.org/10.1007/s10549-018-5028-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8147582/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30406364/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Skuli%20SJ,%20Sheng%20JY,%20Bantug%20ET,%20et%20al.%20Survivorship%20care%20visits%20in%20a%20high-risk%20population%20of%20breast%20cancer%20survivors.%20Breast%20Cancer%20Res%20Treat.%202019;173(3):701%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Early Breast Cancer Trialists’ Collaborative G. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-y survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687–717.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(05)66544-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15894097/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Early%20Breast%20Cancer%20Trialists%E2%80%99%20Collaborative%20G.%20Effects%20of%20chemotherapy%20and%20hormonal%20therapy%20for%20early%20breast%20cancer%20on%20recurrence%20and%2015-y%20survival:%20an%20overview%20of%20the%20randomised%20trials.%20Lancet.%202005;365(9472):1687%E2%80%93717." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Abdelnaby RM, Rateb HS, Ali O, et al. Dual PI3K/Akt inhibitors bearing coumarin-thiazolidine pharmacophores as potential apoptosis inducers in MCF-7 cells. Pharmaceuticals (Basel). 2022;15(4): 428. 10.3390/ph15040428.
</cite> [<a href="https://doi.org/10.3390/ph15040428" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9027131/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35455425/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Abdelnaby%20RM,%20Rateb%20HS,%20Ali%20O,%20et%20al.%20Dual%20PI3K/Akt%20inhibitors%20bearing%20coumarin-thiazolidine%20pharmacophores%20as%20potential%20apoptosis%20inducers%20in%20MCF-7%20cells.%20Pharmaceuticals%20(Basel).%202022;15(4):%20428.%2010.3390/ph15040428." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Ren Q, Zhang L, Ruoff R, et al. Expression of androgen receptor and its phosphorylated forms in breast cancer progression. Cancer. 2013;119(14):2532–40. 10.1002/cncr.28092.
</cite> [<a href="https://doi.org/10.1002/cncr.28092" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3874891/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23605249/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ren%20Q,%20Zhang%20L,%20Ruoff%20R,%20et%20al.%20Expression%20of%20androgen%20receptor%20and%20its%20phosphorylated%20forms%20in%20breast%20cancer%20progression.%20Cancer.%202013;119(14):2532%E2%80%9340.%2010.1002/cncr.28092." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Jardim DL, Millis SZ, Ross JS, et al. Landscape of cyclin pathway genomic alterations across 5,356 prostate cancers: implications for targeted therapeutics. Oncologist. 2021;26(4):e715–8. 10.1002/onco.13694.
</cite> [<a href="https://doi.org/10.1002/onco.13694" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8018295/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33522043/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jardim%20DL,%20Millis%20SZ,%20Ross%20JS,%20et%20al.%20Landscape%20of%20cyclin%20pathway%20genomic%20alterations%20across%205,356%20prostate%20cancers:%20implications%20for%20targeted%20therapeutics.%20Oncologist.%202021;26(4):e715%E2%80%938.%2010.1002/onco.13694." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Liu B, Su Q, Ma J, et al. Prognostic value of eight-gene signature in head and neck squamous carcinoma. Front Oncol. 2021;11: 657002. 10.3389/fonc.2021.657002.
</cite> [<a href="https://doi.org/10.3389/fonc.2021.657002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8252784/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34221975/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20B,%20Su%20Q,%20Ma%20J,%20et%20al.%20Prognostic%20value%20of%20eight-gene%20signature%20in%20head%20and%20neck%20squamous%20carcinoma.%20Front%20Oncol.%202021;11:%20657002.%2010.3389/fonc.2021.657002." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Gong C, Man EPS, Tsoi H, et al. BQ323636.1, a novel splice variant to NCOR 2, as a predictor for tamoxifen-resistant breast cancer. Clin Cancer Res. 2018;24(15):3681–91. 10.1158/1078-0432.CCR-17-2259.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-17-2259" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6038915/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29420220/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gong%20C,%20Man%20EPS,%20Tsoi%20H,%20et%20al.%20BQ323636.1,%20a%20novel%20splice%20variant%20to%20NCOR%202,%20as%20a%20predictor%20for%20tamoxifen-resistant%20breast%20cancer.%20Clin%20Cancer%20Res.%202018;24(15):3681%E2%80%9391.%2010.1158/1078-0432.CCR-17-2259." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Okano M, Oshi M, Butash AL, et al. Estrogen receptor positive breast cancer with high expression of androgen receptor has less cytolytic activity and worse response to neoadjuvant chemotherapy but better survival. Int J Mol Sci. 2019. 10.3390/ijms20112655.
</cite> [<a href="https://doi.org/10.3390/ijms20112655" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6600230/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31151151/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Okano%20M,%20Oshi%20M,%20Butash%20AL,%20et%20al.%20Estrogen%20receptor%20positive%20breast%20cancer%20with%20high%20expression%20of%20androgen%20receptor%20has%20less%20cytolytic%20activity%20and%20worse%20response%20to%20neoadjuvant%20chemotherapy%20but%20better%20survival.%20Int%20J%20Mol%20Sci.%202019.%2010.3390/ijms20112655." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Ding M, Wu J, Sun R, et al. Androgen receptor transactivates KSHV noncoding RNA PAN to promote lytic replication-mediated oncogenesis: a mechanism of sex disparity in KS. PLoS Pathog. 2021;17(9): e1009947. 10.1371/journal.ppat.1009947.
</cite> [<a href="https://doi.org/10.1371/journal.ppat.1009947" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8483343/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34543357/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ding%20M,%20Wu%20J,%20Sun%20R,%20et%20al.%20Androgen%20receptor%20transactivates%20KSHV%20noncoding%20RNA%20PAN%20to%20promote%20lytic%20replication-mediated%20oncogenesis:%20a%20mechanism%20of%20sex%20disparity%20in%20KS.%20PLoS%20Pathog.%202021;17(9):%20e1009947.%2010.1371/journal.ppat.1009947." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Chng KR, Chang CW, Tan SK, et al. A transcriptional repressor co-regulatory network governing androgen response in prostate cancers. EMBO J. 2012;31(12):2810–23. 10.1038/emboj.2012.112.
</cite> [<a href="https://doi.org/10.1038/emboj.2012.112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3380210/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22531786/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chng%20KR,%20Chang%20CW,%20Tan%20SK,%20et%20al.%20A%20transcriptional%20repressor%20co-regulatory%20network%20governing%20androgen%20response%20in%20prostate%20cancers.%20EMBO%20J.%202012;31(12):2810%E2%80%9323.%2010.1038/emboj.2012.112." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Jahan N, Jones C, Rahman RL. Androgen receptor expression in breast cancer: implications on prognosis and treatment, a brief review. Mol Cell Endocrinol. 2021;531: 111324.
</cite> [<a href="https://doi.org/10.1016/j.mce.2021.111324" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34000352/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jahan%20N,%20Jones%20C,%20Rahman%20RL.%20Androgen%20receptor%20expression%20in%20breast%20cancer:%20implications%20on%20prognosis%20and%20treatment,%20a%20brief%20review.%20Mol%20Cell%20Endocrinol.%202021;531:%20111324." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Kensler KH, Regan MM, Heng YJ, et al. Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1–98. Breast Cancer Res. 2019;21(1): 30. 10.1186/s13058-019-1118-z.
</cite> [<a href="https://doi.org/10.1186/s13058-019-1118-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6387478/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30795773/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kensler%20KH,%20Regan%20MM,%20Heng%20YJ,%20et%20al.%20Prognostic%20and%20predictive%20value%20of%20androgen%20receptor%20expression%20in%20postmenopausal%20women%20with%20estrogen%20receptor-positive%20breast%20cancer:%20results%20from%20the%20Breast%20International%20Group%20Trial%201%E2%80%9398.%20Breast%20Cancer%20Res.%202019;21(1):%2030.%2010.1186/s13058-019-1118-z." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Vasiliou SK, Diamandis EP. Androgen receptor: a promising therapeutic target in breast cancer. Crit Rev Clin Lab Sci. 2019;56(3):200–23.
</cite> [<a href="https://doi.org/10.1080/10408363.2019.1575643" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30821186/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vasiliou%20SK,%20Diamandis%20EP.%20Androgen%20receptor:%20a%20promising%20therapeutic%20target%20in%20breast%20cancer.%20Crit%20Rev%20Clin%20Lab%20Sci.%202019;56(3):200%E2%80%9323." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Jiang HS, Kuang XY, Sun WL. Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status. Oncotarget. 2016;7(27):41285–93.
</cite> [<a href="https://doi.org/10.18632/oncotarget.9778" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5173059/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27285752/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jiang%20HS,%20Kuang%20XY,%20Sun%20WL.%20Androgen%20receptor%20expression%20predicts%20different%20clinical%20outcomes%20for%20breast%20cancer%20patients%20stratified%20by%20hormone%20receptor%20status.%20Oncotarget.%202016;7(27):41285%E2%80%9393." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Kensler KH, Regan MM, Heng YJ, et al. Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1–98. Breast Cancer Res. 2019;21(1): 30.
</cite> [<a href="https://doi.org/10.1186/s13058-019-1118-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6387478/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30795773/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kensler%20KH,%20Regan%20MM,%20Heng%20YJ,%20et%20al.%20Prognostic%20and%20predictive%20value%20of%20androgen%20receptor%20expression%20in%20postmenopausal%20women%20with%20estrogen%20receptor-positive%20breast%20cancer:%20results%20from%20the%20Breast%20International%20Group%20Trial%201%E2%80%9398.%20Breast%20Cancer%20Res.%202019;21(1):%2030." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Kensler KH, Poole EM, Heng YJ, et al. Androgen receptor expression and breast cancer survival: results from the Nurses’ Health Studies. J Natl Cancer Inst. 2019;111(7):700–8.
</cite> [<a href="https://doi.org/10.1093/jnci/djy173" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6624168/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30445651/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kensler%20KH,%20Poole%20EM,%20Heng%20YJ,%20et%20al.%20Androgen%20receptor%20expression%20and%20breast%20cancer%20survival:%20results%20from%20the%20Nurses%E2%80%99%20Health%20Studies.%20J%20Natl%20Cancer%20Inst.%202019;111(7):700%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>McGhan LJ, McCullough AE, Protheroe CA, et al. Androgen receptor-positive triple negative breast cancer: a unique breast cancer subtype. Ann Surg Oncol. 2014;21(2):361–7.
</cite> [<a href="https://doi.org/10.1245/s10434-013-3260-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24046116/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?McGhan%20LJ,%20McCullough%20AE,%20Protheroe%20CA,%20et%20al.%20Androgen%20receptor-positive%20triple%20negative%20breast%20cancer:%20a%20unique%20breast%20cancer%20subtype.%20Ann%20Surg%20Oncol.%202014;21(2):361%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Pistelli M, Caramanti M, Biscotti T, et al. Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations. Cancers (Basel). 2014;6(3):1351–62.
</cite> [<a href="https://doi.org/10.3390/cancers6031351" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4190544/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24978437/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pistelli%20M,%20Caramanti%20M,%20Biscotti%20T,%20et%20al.%20Androgen%20receptor%20expression%20in%20early%20triple-negative%20breast%20cancer:%20clinical%20significance%20and%20prognostic%20associations.%20Cancers%20(Basel).%202014;6(3):1351%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Wang J, Fu H, Zhong Z, et al. Local and systemic therapy may be safely de-escalated in elderly breast cancer patients in China: a retrospective cohort study. Front Oncol. 2022;12: 958116. 10.3389/fonc.2022.958116.
</cite> [<a href="https://doi.org/10.3389/fonc.2022.958116" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9371841/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35965508/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20J,%20Fu%20H,%20Zhong%20Z,%20et%20al.%20Local%20and%20systemic%20therapy%20may%20be%20safely%20de-escalated%20in%20elderly%20breast%20cancer%20patients%20in%20China:%20a%20retrospective%20cohort%20study.%20Front%20Oncol.%202022;12:%20958116.%2010.3389/fonc.2022.958116." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Tobin NP, Harrell JC, Lövrot J, et al. Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival. Ann Oncol. 2015;26(1):81–8. 10.1093/annonc/mdu498.
</cite> [<a href="https://doi.org/10.1093/annonc/mdu498" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4269343/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25361981/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tobin%20NP,%20Harrell%20JC,%20L%C3%B6vrot%20J,%20et%20al.%20Molecular%20subtype%20and%20tumor%20characteristics%20of%20breast%20cancer%20metastases%20as%20assessed%20by%20gene%20expression%20significantly%20influence%20patient%20post-relapse%20survival.%20Ann%20Oncol.%202015;26(1):81%E2%80%938.%2010.1093/annonc/mdu498." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Wellberg EA, Kabos P, Gillen AE, et al. FGFR1 underlies obesity-associated progression of estrogen receptor-positive breast cancer after estrogen deprivation. JCI Insight. 2018. 10.1172/jci.insight.120594.
</cite> [<a href="https://doi.org/10.1172/jci.insight.120594" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6124402/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30046001/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wellberg%20EA,%20Kabos%20P,%20Gillen%20AE,%20et%20al.%20FGFR1%20underlies%20obesity-associated%20progression%20of%20estrogen%20receptor-positive%20breast%20cancer%20after%20estrogen%20deprivation.%20JCI%20Insight.%202018.%2010.1172/jci.insight.120594." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Zhuang T, Wang B, Tan X, et al. TRIM3 facilitates estrogen signaling and modulates breast cancer cell progression. Cell Commun Signal. 2022;20(1):45. 10.1186/s12964-022-00861-z.
</cite> [<a href="https://doi.org/10.1186/s12964-022-00861-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8991925/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35392925/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhuang%20T,%20Wang%20B,%20Tan%20X,%20et%20al.%20TRIM3%20facilitates%20estrogen%20signaling%20and%20modulates%20breast%20cancer%20cell%20progression.%20Cell%20Commun%20Signal.%202022;20(1):45.%2010.1186/s12964-022-00861-z." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>De Amicis F, Thirugnansampanthan J, Cui Y, et al. Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells. Breast Cancer Res Treat. 2010;121(1):1–11.
</cite> [<a href="https://doi.org/10.1007/s10549-009-0436-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2995248/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19533338/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?De%20Amicis%20F,%20Thirugnansampanthan%20J,%20Cui%20Y,%20et%20al.%20Androgen%20receptor%20overexpression%20induces%20tamoxifen%20resistance%20in%20human%20breast%20cancer%20cells.%20Breast%20Cancer%20Res%20Treat.%202010;121(1):1%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Cochrane DR, Bernales S, Jacobsen BM, et al. Role of the androgen receptor inbreast cancer and preclinical analysis of enzalutamide. Breast Cancer Res. 2014;16(1): R7.
</cite> [<a href="https://doi.org/10.1186/bcr3599" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3978822/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24451109/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cochrane%20DR,%20Bernales%20S,%20Jacobsen%20BM,%20et%20al.%20Role%20of%20the%20androgen%20receptor%20inbreast%20cancer%20and%20preclinical%20analysis%20of%20enzalutamide.%20Breast%20Cancer%20Res.%202014;16(1):%20R7." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Allison KH, Hammond MEH, Dowsett M, et al. Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update. Arch Pathol Lab Med. 2020;144(5):545–63. 10.5858/arpa.2019-0904-SAIF:4.6Q1.
</cite> [<a href="https://doi.org/10.5858/arpa.2019-0904-SA" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31928354/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Allison%20KH,%20Hammond%20MEH,%20Dowsett%20M,%20et%20al.%20Estrogen%20and%20Progesterone%20Receptor%20Testing%20in%20Breast%20Cancer:%20American%20Society%20of%20Clinical%20Oncology/College%20of%20American%20Pathologists%20Guideline%20Update.%20Arch%20Pathol%20Lab%20Med.%202020;144(5):545%E2%80%9363.%2010.5858/arpa.2019-0904-SAIF:4.6Q1." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Zhang YC, Zeng PY, Ma ZQ, et al. A pH-responsive complex based on supramolecular organic framework for drug-resistant breast cancer therapy. Drug Deliv. 2022;29(1):128–37. 10.1080/10717544.2021.2021325.
</cite> [<a href="https://doi.org/10.1080/10717544.2021.2021325" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8725931/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34967270/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20YC,%20Zeng%20PY,%20Ma%20ZQ,%20et%20al.%20A%20pH-responsive%20complex%20based%20on%20supramolecular%20organic%20framework%20for%20drug-resistant%20breast%20cancer%20therapy.%20Drug%20Deliv.%202022;29(1):128%E2%80%9337.%2010.1080/10717544.2021.2021325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Vera-Badillo FE, Templeton AJ, de Gouveia P, et al. Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(1): djt319.
</cite> [<a href="https://doi.org/10.1093/jnci/djt319" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24273215/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vera-Badillo%20FE,%20Templeton%20AJ,%20de%20Gouveia%20P,%20et%20al.%20Androgen%20receptor%20expression%20and%20outcomes%20in%20early%20breast%20cancer:%20a%20systematic%20review%20and%20meta-analysis.%20J%20Natl%20Cancer%20Inst.%202014;106(1):%20djt319." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Yang Y, Min A, Lee KH, et al. Prognostic role of androgen receptor expression in surgically resected early breast cancer patients. J Breast Cancer. 2020;23(2):182–93.
</cite> [<a href="https://doi.org/10.4048/jbc.2020.23.e28" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7192742/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32395377/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20Y,%20Min%20A,%20Lee%20KH,%20et%20al.%20Prognostic%20role%20of%20androgen%20receptor%20expression%20in%20surgically%20resected%20early%20breast%20cancer%20patients.%20J%20Breast%20Cancer.%202020;23(2):182%E2%80%9393." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Agoff SN, Swanson PE, Linden H, et al. Androgen receptor expression in estrogen receptor-negative breast cancer Immunohistochemical, clinical, and prognostic associations. Am J Clin Pathol. 2003;120(5):725–31.
</cite> [<a href="https://doi.org/10.1309/42F0-0D0D-JD0J-5EDT" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14608899/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Agoff%20SN,%20Swanson%20PE,%20Linden%20H,%20et%20al.%20Androgen%20receptor%20expression%20in%20estrogen%20receptor-negative%20breast%20cancer%20Immunohistochemical,%20clinical,%20and%20prognostic%20associations.%20Am%20J%20Clin%20Pathol.%202003;120(5):725%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>He J, Peng R, Yuan Z, et al. Prognostic value of androgen receptor expression inoperable triple-negative breast cancer: a retrospective analysis based on a tissue microarray. Med Oncol. 2012;29(2):406–10.
</cite> [<a href="https://doi.org/10.1007/s12032-011-9832-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21264529/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?He%20J,%20Peng%20R,%20Yuan%20Z,%20et%20al.%20Prognostic%20value%20of%20androgen%20receptor%20expression%20inoperable%20triple-negative%20breast%20cancer:%20a%20retrospective%20analysis%20based%20on%20a%20tissue%20microarray.%20Med%20Oncol.%202012;29(2):406%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Ricciardelli C, Bianco-Miotto T, Jindal S, et al. The magnitude of androgen receptor positivity in breast cancer is critical for reliable prediction of disease outcome. Clin Cancer Res. 2018;24(10):2328–41.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-17-1199" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29514843/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ricciardelli%20C,%20Bianco-Miotto%20T,%20Jindal%20S,%20et%20al.%20The%20magnitude%20of%20androgen%20receptor%20positivity%20in%20breast%20cancer%20is%20critical%20for%20reliable%20prediction%20of%20disease%20outcome.%20Clin%20Cancer%20Res.%202018;24(10):2328%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Elebro K, Borgquist S, Simonsson M, et al. Combined androgen and estrogen receptor status in breast cancer: treatment prediction and prognosis in a population-based prospective cohort. Clin Cancer Res. 2015;21(16):3640–50.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-14-2564" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25904752/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Elebro%20K,%20Borgquist%20S,%20Simonsson%20M,%20et%20al.%20Combined%20androgen%20and%20estrogen%20receptor%20status%20in%20breast%20cancer:%20treatment%20prediction%20and%20prognosis%20in%20a%20population-based%20prospective%20cohort.%20Clin%20Cancer%20Res.%202015;21(16):3640%E2%80%9350." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Bronte G, Bravaccini S, Ravaioli S, et al. Androgen receptor expression in breast cancer: what differences between primary tumor and metastases? Transl Oncol. 2018;11(4):950–6.
</cite> [<a href="https://doi.org/10.1016/j.tranon.2018.05.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6036224/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29890379/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bronte%20G,%20Bravaccini%20S,%20Ravaioli%20S,%20et%20al.%20Androgen%20receptor%20expression%20in%20breast%20cancer:%20what%20differences%20between%20primary%20tumor%20and%20metastases?%20Transl%20Oncol.%202018;11(4):950%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Collins LC, Cole KS, Marotti JD, et al. Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the nurses’ health study. Mod Pathol. 2011;24(7):924–31.
</cite> [<a href="https://doi.org/10.1038/modpathol.2011.54" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3128675/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21552212/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Collins%20LC,%20Cole%20KS,%20Marotti%20JD,%20et%20al.%20Androgen%20receptor%20expression%20in%20breast%20cancer%20in%20relation%20to%20molecular%20phenotype:%20results%20from%20the%20nurses%E2%80%99%20health%20study.%20Mod%20Pathol.%202011;24(7):924%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Lanzino M, De Amicis F, McPhaul MJ, et al. Endogenous coactivator ARA70 interacts with estrogen receptor alpha (ERalpha) and modulates the functional ERalpha/androgen receptor interplay in MCF-7 cells. J Biol Chem. 2005;280(21):20421–30.
</cite> [<a href="https://doi.org/10.1074/jbc.M413576200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15772083/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lanzino%20M,%20De%20Amicis%20F,%20McPhaul%20MJ,%20et%20al.%20Endogenous%20coactivator%20ARA70%20interacts%20with%20estrogen%20receptor%20alpha%20(ERalpha)%20and%20modulates%20the%20functional%20ERalpha/androgen%20receptor%20interplay%20in%20MCF-7%20cells.%20J%20Biol%20Chem.%202005;280(21):20421%E2%80%9330." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Rangel N, Rondon-Lagos M, Annaratone L, et al. The role of the AR/ER ratio in ER-positive breast cancer patients. Endocr Relat Cancer. 2018;25(3):163–72.
</cite> [<a href="https://doi.org/10.1530/ERC-17-0417" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29386247/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rangel%20N,%20Rondon-Lagos%20M,%20Annaratone%20L,%20et%20al.%20The%20role%20of%20the%20AR/ER%20ratio%20in%20ER-positive%20breast%20cancer%20patients.%20Endocr%20Relat%20Cancer.%202018;25(3):163%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Prabhu JS, Korlimarla A, Rajarajan S, et al. Abstract PS6-55: the prognostic utility of AR/ER ratio in young women with breast cancer. Cancer Res. 2021. 10.1158/1538-7445.SABCS20-PS6-55.
</cite> [<a href="https://doi.org/10.1158/1538-7445.SABCS20-PS6-55" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7611542/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34421401/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Prabhu%20JS,%20Korlimarla%20A,%20Rajarajan%20S,%20et%20al.%20Abstract%20PS6-55:%20the%20prognostic%20utility%20of%20AR/ER%20ratio%20in%20young%20women%20with%20breast%20cancer.%20Cancer%20Res.%202021.%2010.1158/1538-7445.SABCS20-PS6-55." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Varga Z, Diebold J, Dommann-Scherrer C, et al. How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists. PLoS ONE. 2012;7(5): e37379.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0037379" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3360682/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22662150/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Varga%20Z,%20Diebold%20J,%20Dommann-Scherrer%20C,%20et%20al.%20How%20reliable%20is%20Ki-67%20immunohistochemistry%20in%20grade%202%20breast%20carcinomas?%20A%20QA%20study%20of%20the%20Swiss%20Working%20Group%20of%20Breast-%20and%20Gynecopathologists.%20PLoS%20ONE.%202012;7(5):%20e37379." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Denkert C, Budczies J, von Minckwitz G, et al. Strategies for developing Ki67 as a useful biomarker in breast cancer. Breast. 2015;24(Suppl 2):S67-72.
</cite> [<a href="https://doi.org/10.1016/j.breast.2015.07.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26283598/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Denkert%20C,%20Budczies%20J,%20von%20Minckwitz%20G,%20et%20al.%20Strategies%20for%20developing%20Ki67%20as%20a%20useful%20biomarker%20in%20breast%20cancer.%20Breast.%202015;24(Suppl%202):S67-72." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>No datasets were generated or analysed during the current study.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from European Journal of Medical Research are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s40001-025-03072-7"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/40001_2025_Article_3072.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.5 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12374384/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12374384/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12374384%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374384/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12374384/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12374384/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40846987/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12374384/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40846987/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12374384/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12374384/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="F18lCjmPsFkhx4XlJZDBWMaffNrpGu71oD447RDsdhCyfkWWo3OXpKSUARlyxqXX">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
